<SEC-DOCUMENT>0001104659-25-020352.txt : 20250304
<SEC-HEADER>0001104659-25-020352.hdr.sgml : 20250304
<ACCEPTANCE-DATETIME>20250304163147
ACCESSION NUMBER:		0001104659-25-020352
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20250304
DATE AS OF CHANGE:		20250304

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CANADIAN IMPERIAL BANK OF COMMERCE /CAN/
		CENTRAL INDEX KEY:			0001045520
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-272447
		FILM NUMBER:		25705211

	BUSINESS ADDRESS:	
		STREET 1:		81 BAY STREET
		STREET 2:		CIBC SQUARE
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5J 0E7
		BUSINESS PHONE:		4169803096

	MAIL ADDRESS:	
		STREET 1:		81 BAY STREET
		STREET 2:		CIBC SQUARE
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5J 0E7
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>tm257948d7_424b2.htm
<DESCRIPTION>424B2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 7.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>Filed
Pursuant to Rule 424(b)(2)</B></P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><B>Registration No. 333-272447</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Arial, Helvetica, Sans-Serif">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 54%; font-size: 8pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">PRICING SUPPLEMENT dated February 28&lrm;&rlm;&rlm;&lrm;, 2025</FONT></TD>
    <TD ROWSPAN="4" STYLE="text-align: right; width: 46%; font-size: 8pt">&nbsp;<IMG SRC="tm257948d7_424b2img001.jpg" ALT=""></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(To Equity Index Underlying Supplement dated September 5, 2023,</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Prospectus Supplement dated September 5, 2023 and</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 8pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Prospectus dated September 5, 2023)</FONT></TD></TR>
  </TABLE>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-family: Arial, Helvetica, Sans-Serif"><TR STYLE="vertical-align: top"><TD STYLE="padding: 3pt 5.4pt; background-color: rgb(238,236,225); width: 100%"><P STYLE="text-align: center; font: 17pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #bb0026"><B>Canadian Imperial Bank of Commerce</B></P>
                                                                                                                                                                                                                                                                                    <P STYLE="font: 17pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #bb0026"><B><B>$4,725,000</B></B></P>
                                                                                                                                                                                                                                                                                    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: rgb(187,0,38)"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Senior
                                            Global Medium-Term Notes</B></FONT></P>
                                                                                                                                                                                                                                                                                    <P STYLE="font: 17pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; color: #bb0026"><B>Leveraged EURO STOXX 50<SUP>&reg;</SUP>
    Index-Linked Notes due March&nbsp;4,<BR>
 2030</B></P></TD></TR></TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The notes do not bear interest.</B> The amount
that you will be paid on your notes on the stated maturity date (March&nbsp;4, 2030, subject to adjustment) is based on the performance
of the EURO STOXX 50<SUP>&reg;</SUP> Index (the &ldquo;underlier&rdquo;) as measured from the trade date to and including the determination
date (February&nbsp;28, 2030, subject to adjustment). If the final underlier level on the determination date is <I>greater than</I> the
initial underlier level (5,463.54, which was the closing level of the underlier on the trade date), the return on your notes will be positive
and will equal the upside participation rate of 2.261 times the underlier return. <B>If the final underlier level is less than the initial
underlier level, the return on your notes will be negative. You could lose your entire investment in the notes.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">To determine your payment at maturity, we will calculate
the underlier return, which is the percentage increase or decrease in the final underlier level from the initial underlier level. On the
stated maturity date, for each $1,000 principal amount of your notes, you will receive an amount in cash equal to:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">if the underlier return is <I>positive</I> (i.e.
the final underlier level is <I>greater than</I> the initial underlier level), the <I>sum</I> of (i)&nbsp;$1,000 <I>plus</I> (ii)&nbsp;the
<I>product</I> of (a)&nbsp;$1,000 <I>times</I> (b)&nbsp;the upside participation rate <I>times</I> (c)&nbsp;the underlier return; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">if the underlier return is <I>zero</I> or <I>negative</I>
(i.e. the final underlier level is <I>equal to</I> or <I>less than</I> the initial underlier level), the <I>sum</I> of (i)&nbsp;$1,000
<I>plus</I> (ii)&nbsp;the <I>product</I> of (a)&nbsp;the underlier return <I>times</I> (b)&nbsp;$1,000. <B>If the underlier return is
negative, this amount will be less than $1,000 and may be zero.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The notes have complex features and investing
in the notes involves risks not associated with an investment in conventional debt securities. See &ldquo;Additional Risk Factors Specific
to Your Notes&rdquo; beginning on page&nbsp;PRS-9 of this Pricing Supplement and &ldquo;Risk Factors&rdquo; beginning on page&nbsp;S-1
of the accompanying Underlying Supplement.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Our estimated value of the notes on the trade date,
based on our internal pricing models, is $928.40 per note. The estimated value is less than the initial issue price of the notes. See
 &ldquo;Additional Information Regarding Estimated Value of the Notes&rdquo; in this Pricing Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 20%; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="text-align: center; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Initial Issue Price</B></FONT></TD>
    <TD STYLE="text-align: center; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Price to Public</B></FONT></TD>
    <TD STYLE="text-align: center; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Agent&rsquo;s Commission</B></FONT></TD>
    <TD STYLE="text-align: center; width: 20%; border-top: Black 1pt solid; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Proceeds to Issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Per Note</B></FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100.00%</FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3.75%</FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">96.25%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Total</B></FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">$4,725,000.00</FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">$4,725,000.00</FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">$177,187.50</FONT></TD>
    <TD STYLE="text-align: center; border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">$4,547,812.50</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>The notes are unsecured obligations of Canadian
Imperial Bank of Commerce and all payments on the notes are subject to the credit risk of Canadian Imperial Bank of Commerce. The notes
will not constitute deposits insured by the Canada Deposit Insurance Corporation, the U.S. Federal Deposit Insurance Corporation or any
other government agency or instrumentality of Canada, the United States or any other jurisdiction. The notes are not bail-inable debt
securities (as defined on page&nbsp;6 of the Prospectus). The notes will not be listed on any U.S. securities exchange.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>Neither the United States Securities and Exchange
Commission (the &ldquo;SEC&rdquo;) nor any state or provincial securities commission has approved or disapproved of these securities or
determined if this Pricing Supplement or the accompanying Underlying Supplement, Prospectus Supplement or Prospectus is truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The issue price, agent&rsquo;s commission and net
proceeds listed above relate to the notes we will sell initially. We may decide to sell additional notes after the trade date, at issue
prices and with agent&rsquo;s commissions and net proceeds that differ from the amounts set forth above. The return (whether positive
or negative) on your investment will depend in part on the issue price you pay for your notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Bank may use this Pricing Supplement in the
initial sale of the notes. Goldman Sachs&nbsp;&amp; Co. LLC (&ldquo;GS&amp;Co.&rdquo;) or any of its affiliates or agents may use this
Pricing Supplement in a market-making transaction in a note after its initial sale. Unless we, GS&amp;Co. or any of our or its respective
affiliates or agents informs the purchaser otherwise in the confirmation of sale, this Pricing Supplement is being used in a market-making
transaction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>We will deliver the notes in book-entry form
through the facilities of The Depository Trust Company (&ldquo;DTC&rdquo;) on March&nbsp;7, 2025 against payment in immediately available
funds.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 16pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 16pt"><B>Goldman
Sachs&nbsp;&amp; Co. LLC</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ADDITIONAL INFORMATION REGARDING ESTIMATED VALUE
OF THE NOTES</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">On the cover page&nbsp;of this Pricing Supplement,
the Bank has provided the initial estimated value range for the notes. This range of estimated values was determined by reference to the
Bank&rsquo;s internal pricing models, which take into consideration certain factors, such as the Bank&rsquo;s internal funding rate on
the trade date and the Bank&rsquo;s assumptions about market parameters. For more information about the initial estimated value, see &ldquo;Additional
Risk Factors Specific to Your Notes&rdquo; beginning on page&nbsp;PRS-9 herein.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The economic terms of the notes (including the
upside participation rate) are based on the Bank&rsquo;s internal funding rate, which is the rate the Bank would pay to borrow funds through
the issuance of similar market-linked notes, the agent&rsquo;s commission and the economic terms of certain related hedging arrangements.
Due to these factors, the initial issue price you pay to purchase the notes is greater than the initial estimated value of the notes.
The Bank&rsquo;s internal funding rate is typically lower than the rate the Bank would pay when it issues conventional fixed rate debt
securities, as discussed further under &ldquo;Additional Risk Factors Specific to Your Notes &mdash; Neither the Bank&rsquo;s nor GS&amp;Co.&rsquo;s
Estimated Value of the Notes at Any Time Is Determined by Reference to Credit Spreads or the Borrowing Rate the Bank Would Pay for Its
Conventional Fixed-Rate Debt Securities&rdquo; in this Pricing Supplement. The Bank&rsquo;s use of its internal funding rate reduces the
economic terms of the notes to you.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The value of your notes at any time will reflect
many factors and cannot be predicted; however, the price (not including GS&amp;Co.&rsquo;s customary bid and ask spreads) at which GS&amp;Co.
would initially buy or sell notes in the secondary market (if GS&amp;Co. makes a market, which it is not obligated to do) and the value
that GS&amp;Co. will initially use for account statements and otherwise is equal to approximately GS&amp;Co.&rsquo;s estimate of the market
value of your notes on the trade date, based on its pricing models and taking into account the Bank&rsquo;s internal funding rate, plus
an additional amount (initially equal to $80.00 per $1,000 principal amount).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Prior to May&nbsp;28, 2025, the price (not including
GS&amp;Co.&rsquo;s customary bid and ask spreads) at which GS&amp;Co. would buy or sell your notes (if it makes a market, which it is
not obligated to do) will equal approximately the sum of (a)&nbsp;the then-current estimated value of your notes (as determined by reference
to GS&amp;Co.&rsquo;s pricing models) plus (b)&nbsp;any remaining additional amount (the additional amount will decline to zero on a straight-line
basis from the time of pricing through May&nbsp;27, 2025). On and after May&nbsp;28, 2025, the price (not including GS&amp;Co.&rsquo;s
customary bid and ask spreads) at which GS&amp;Co. would buy or sell your notes (if it makes a market) will equal approximately the then-current
estimated value of your notes determined by reference to such pricing models. For additional information regarding the value of your notes
shown in your GS&amp;Co. account statements and the price at which GS&amp;Co. would buy or sell your notes (if GS&amp;Co. makes a market,
which it is not obligated to do), each based on GS&amp;Co.&rsquo;s pricing models; see &ldquo;Additional Risk Factors Specific to Your
Notes &mdash; The Price at Which GS&amp;Co. Would Buy Or Sell Your Notes (If GS&amp;Co. Makes a Market, Which It Is Not Obligated To Do)
Will Be Based on GS&amp;Co.&rsquo;s Estimated Value of Your Notes&rdquo; below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>ABOUT THIS PRICING SUPPLEMENT</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">You should read this Pricing Supplement together
with the Prospectus dated September&nbsp;5, 2023 (the &ldquo;Prospectus&rdquo;), the Prospectus Supplement dated September&nbsp;5, 2023
(the &ldquo;Prospectus Supplement&rdquo;) and the Equity Index Underlying Supplement dated September&nbsp;5, 2023 (the &ldquo;Underlying
Supplement&rdquo;), each relating to our Senior Global Medium-Term Notes, for additional information about the notes. Information in this
Pricing Supplement supersedes information in the accompanying Underlying Supplement, Prospectus Supplement and Prospectus to the extent
it is different from that information. Certain defined terms used but not defined herein have the meanings set forth in the accompanying
Underlying Supplement, Prospectus Supplement or Prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">You should rely only on the information contained
in or incorporated by reference in this Pricing Supplement and the accompanying Underlying Supplement, Prospectus Supplement and Prospectus.
This Pricing Supplement may be used only for the purpose for which it has been prepared. No one is authorized to give information other
than that contained in this Pricing Supplement and the accompanying Underlying Supplement, Prospectus Supplement and Prospectus, and in
the documents referred to in these documents and which are made available to the public. We have not, and GS&amp;Co. has not, authorized
any other person to provide you with different or additional information. If anyone provides you with different or additional information,
you should not rely on it.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We are not, and GS&amp;Co. is not, making an offer
to sell the notes in any jurisdiction where the offer or sale is not permitted. You should not assume that the information contained in
or incorporated by reference in this Pricing Supplement or the accompanying Underlying Supplement, Prospectus Supplement or Prospectus
is accurate as of any date other than the date of the applicable document. Our business, financial condition, results of operations and
prospects may have changed since that date. Neither this Pricing Supplement nor the accompanying Underlying Supplement, Prospectus Supplement
or Prospectus constitutes an offer, or an invitation on our behalf or on behalf of GS&amp;Co., to subscribe for and purchase any of the
notes and may not be used for or in connection with an offer or solicitation by anyone in any jurisdiction in which such an offer or solicitation
is not authorized or to any person to whom it is unlawful to make such an offer or solicitation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">References to &ldquo;CIBC,&rdquo; &ldquo;the Issuer,&rdquo;
 &ldquo;the Bank,&rdquo; &ldquo;we,&rdquo; &ldquo;us&rdquo; and &ldquo;our&rdquo; in this Pricing Supplement are references to Canadian
Imperial Bank of Commerce and not to any of our subsidiaries, unless we state otherwise or the context otherwise requires.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">You may access the accompanying Underlying Supplement,
Prospectus Supplement and Prospectus on the SEC website www.sec.gov as follows (or if such address has changed, by reviewing our filing
for the relevant date on the SEC website):</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Underlying Supplement dated September&nbsp;5,
2023:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1045520/000110465923098170/tm2322483d89_424b5.htm" STYLE="-sec-extract: exhibit">https://www.sec.gov/Archives/edgar/data/1045520/000110465923098170/tm2322483d89_424b5.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Prospectus Supplement dated September&nbsp;5,
2023:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1045520/000110465923098166/tm2322483d94_424b5.htm" STYLE="-sec-extract: exhibit">https://www.sec.gov/Archives/edgar/data/1045520/000110465923098166/tm2322483d94_424b5.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">Prospectus dated September&nbsp;5, 2023:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><A HREF="https://www.sec.gov/Archives/edgar/data/1045520/000110465923098163/tm2325339d10_424b3.htm" STYLE="-sec-extract: exhibit">https://www.sec.gov/Archives/edgar/data/1045520/000110465923098163/tm2325339d10_424b3.htm</A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>SUMMARY INFORMATION</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border: Black 1pt solid; padding: 4pt 5.4pt; text-align: justify; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>We refer to the notes we are offering by this Pricing Supplement as the &ldquo;offered notes&rdquo; or the &ldquo;notes&rdquo;. Each of the offered notes has the terms described below. Terms used but not defined in this Pricing Supplement have the meanings set forth in the accompanying Underlying Supplement, Prospectus Supplement or Prospectus. This section is meant as a summary and should be read in conjunction with the accompanying Prospectus, Prospectus Supplement and Underlying Supplement. This Pricing Supplement supersedes any conflicting provisions of the documents listed above.</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Key Terms</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Issuer:</B></FONT>
Canadian Imperial Bank of Commerce</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Underlier:</B></FONT>
The EURO STOXX 50<SUP>&reg;</SUP> Index (Bloomberg symbol, &ldquo;SX5E Index&rdquo;), as published by STOXX Limited</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Specified currency:</B></FONT>
U.S. dollars (&ldquo;$&rdquo;)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Principal amount:</B></FONT>
Each note will have a principal amount of $1,000; $4,725,000 in the aggregate for all the offered notes; the aggregate principal amount
of the offered notes may be increased if the Issuer, at its sole option, decides to sell an additional amount of the offered notes on
a date subsequent to the trade date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Minimum investment:</B></FONT>
$1,000 (one note)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Denominations:</B></FONT>
$1,000 and integral multiples of $1,000 in excess thereof</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Purchase at amount
other than the principal amount:</B></FONT> The amount we will pay you on the stated maturity date for your notes will not be adjusted
based on the issue price you pay for your notes, so if you acquire notes at a premium (or a discount) to the principal amount and hold
them to the stated maturity date, it could affect your investment in a number of ways. The return on your investment in such notes will
be lower (or higher) than it would have been had you purchased the notes at the principal amount. See &ldquo;Additional Risk Factors Specific
to Your Notes &mdash; If You Purchase Your Notes at a Premium to the Principal Amount, the Return on Your Investment Will Be Lower Than
the Return on Notes Purchased at the Principal Amount and the Impact of Certain Key Terms of the Notes Will Be Negatively Affected&rdquo;
in this Pricing Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Cash settlement
amount (on the stated maturity date):</B></FONT> For each $1,000 principal amount of your notes, we will pay you on the stated maturity
date an amount in cash equal to:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">if the final underlier level is <I>greater than</I>
the initial underlier level, the <I>sum</I> of (i)&nbsp;$1,000 <I>plus</I> (ii)&nbsp;the <I>product</I> of (a)&nbsp;$1,000 <I>times</I>
(b)&nbsp;the upside participation rate <I>times</I> (c)&nbsp;the underlier return; or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">if the final underlier level is <I>equal to</I>
or <I>less than</I> the initial underlier level, the <I>sum</I> of (i)&nbsp;$1,000 <I>plus</I> (ii)&nbsp;the <I>product</I> of (a)&nbsp;the
underlier return <I>times</I> (b)&nbsp;$1,000. <B>If the final underlier level is less than the initial underlier level, the cash settlement
amount will be less than the principal amount of the notes, and you will lose some or all of the principal amount.</B></FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Upside participation
rate:</B></FONT> 226.10%</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Initial underlier
level:</B></FONT> 5,463.54, which was the closing level of the underlier on the trade date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Final underlier
level:</B></FONT> The closing level of the underlier on the determination date</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Underlier return:</B></FONT>
The <I>quotient</I> of (1)&nbsp;the final underlier level <I>minus</I> the initial underlier level <I>divided</I> by (2)&nbsp;the initial
underlier level, expressed as a positive or negative percentage</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Trade date:</B></FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;February&nbsp;28,
2025</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Original issue
date (settlement date):</B></FONT> March&nbsp;7, 2025</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Determination
date:</B></FONT> February&nbsp;28, 2030, subject to adjustment as described under &ldquo;Certain Terms of the Notes&mdash;Valuation Dates&rdquo;
in the accompanying Underlying Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Stated maturity
date:</B></FONT> March&nbsp;4, 2030, subject to adjustment as described under &ldquo;Certain Terms of the Notes&mdash;Interest Payment
Dates, Coupon Payment Dates, Call Payment Dates and Maturity Date&rdquo; in the accompanying Underlying Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Market disruption
event:</B></FONT> With respect to any given trading day, any of the following will be a market disruption event with respect to the underlier:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">a suspension, absence or material limitation of
trading in underlier stocks (as defined below) constituting 20% or more, by weight, of the underlier on their respective primary markets,
in each case for more than two consecutive </FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="text-align: justify">hours of trading or during the one-half hour before the close of trading in that market, as
    determined by the calculation agent in its sole discretion,</TD></TR>
  </TABLE>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">a suspension, absence or material limitation of
trading in option or futures contracts, if available, relating to the underlier or to underlier stocks constituting 20% or more, by weight,
of the underlier in their respective primary markets for those contracts, in each case for more than two consecutive hours of trading
or during the one-half hour before the close of trading in that market, as determined by the calculation agent in its sole discretion,
or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">underlier stocks constituting 20% or more, by
weight, of the underlier, or option or futures contracts, if available, relating to the underlier or to underlier stocks constituting
20% or more, by weight, of the underlier do not trade on what were the respective primary markets for those underlier stocks or contracts,
as determined by the calculation agent in its sole discretion,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">and, in the case of any of these events, the calculation
agent determines in its sole discretion that the event could materially interfere with the ability of us or any of our affiliates or a
similarly situated party to unwind all or a material portion of a hedge that could be effected with respect to the notes. For more information
about hedging by us and/or any of our affiliates, see &ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying Underlying Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The following events will not be market disruption
events with respect to the underlier:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">a limitation on the hours or numbers of days of
trading, but only if the limitation results from an announced change in the regular business hours of the relevant market, and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">a decision to permanently discontinue trading
in the option or futures contracts relating to the underlier or to any underlier stock.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">For this purpose, an &ldquo;absence of trading&rdquo;
in the primary securities market on which an underlier stock, or on which option or futures contracts, if available, relating to the underlier
or to any underlier stock are traded will not include any time when that market is itself closed for trading under ordinary circumstances.
In contrast, a suspension or limitation of trading in an underlier stock or in option or futures contracts, if available, relating to
the underlier or to any underlier stock in the primary market for that stock or those contracts, by reason of:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">a price change exceeding limits set by that market,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">an imbalance of orders relating to that underlier
stock or those contracts, or</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><FONT STYLE="font-family: Symbol">&middot;</FONT></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">a disparity in bid and ask quotes relating to
that underlier stock or those contracts,</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">will constitute a suspension or material limitation
of trading in that underlier stock or those contracts in that market.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Closing level:</B></FONT>
As described under &ldquo;Certain Terms of the Notes &ndash;&ndash; Certain Definitions &ndash;&ndash; Closing Level&rdquo; in the accompanying
Underlying Supplement</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>No listing:</B></FONT>
The offered notes will not be listed on any securities exchange</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>Calculation agent:</B></FONT>
Canadian Imperial Bank of Commerce. We may appoint a different calculation agent without your consent and without notifying you</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>CUSIP / ISIN:</B></FONT>
13607XW78 / US13607XW789</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>SUPPLEMENTAL TERMS OF THE NOTES</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">For purposes of the notes offered by this Pricing
Supplement, all references to each of the following terms used in the accompanying Underlying Supplement will be deemed to refer to the
corresponding term used in this Pricing Supplement, as set forth in the table below:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 3pt 5.4pt 4pt; width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Underlying
    Supplement Term</B></FONT></TD>
    <TD STYLE="padding: 3pt 5.4pt 4pt; width: 50%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>Pricing
    Supplement Term</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 3pt 5.4pt 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Final Valuation Date</FONT></TD>
    <TD STYLE="padding: 3pt 5.4pt 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">determination date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 3pt 5.4pt 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">maturity date</FONT></TD>
    <TD STYLE="padding: 3pt 5.4pt 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">stated maturity date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 3pt 5.4pt 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Reference Asset</FONT></TD>
    <TD STYLE="padding: 3pt 5.4pt 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">underlier</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 3pt 5.4pt 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Index Sponsor</FONT></TD>
    <TD STYLE="padding: 3pt 5.4pt 4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">underlier sponsor</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>HYPOTHETICAL EXAMPLES</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The following table and chart are provided for
purposes of illustration only. They should not be taken as an indication or prediction of future investment results and merely are intended
to illustrate the impact that the various hypothetical final underlier levels on the determination date could have on the cash settlement
amount at maturity assuming all other variables remain constant.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The examples below are based on a range of final
underlier levels that are entirely hypothetical; the underlier level on any day throughout the life of the notes, including the final
underlier level on the determination date, cannot be predicted. The underlier has been highly volatile in the past &mdash; meaning that
the underlier level has changed considerably in relatively short periods &mdash; and its performance cannot be predicted for any future
period.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The information in the following examples reflects
hypothetical rates of return on the offered notes assuming that they are purchased on the original issue date at the principal amount
and held to the stated maturity date. If you sell your notes in a secondary market prior to the stated maturity date, your return will
depend upon the market value of your notes at the time of sale, which may be affected by a number of factors that are not reflected in
the table below, such as interest rates, the volatility of the underlier and the creditworthiness of CIBC. In addition, the estimated
value of your notes at the time the terms of your notes were set on the trade date (as determined by reference to pricing models used
by CIBC) is less than the initial issue price of your notes. For more information on the estimated value of your notes, see &ldquo;Additional
Risk Factors Specific to Your Notes &mdash; The Bank&rsquo;s Initial Estimated Value of the Notes at the Time of Pricing (When the Terms
of Your Notes Were Set on the Trade Date) Is Lower Than the Initial Issue Price of the Notes&rdquo; in this Pricing Supplement and &ldquo;Additional
Information Regarding Estimated Value of the Notes&rdquo; in this Pricing Supplement. The information in the following hypothetical examples
also reflects the key terms and assumptions in the box below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="background-color: Black; vertical-align: top">
    <TD COLSPAN="2" STYLE="color: White; border: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Key Terms and Assumptions</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 24%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Principal amount</B></TD>
    <TD STYLE="width: 76%; border-bottom: Black 1pt solid; border-right: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">$1,000</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Upside participation rate</B></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">226.10%</TD></TR>
  </TABLE>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Neither a market disruption event nor a non-trading day occurs on the
    originally scheduled determination date</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">No change in or affecting any of the underlier
    stocks or the method by which the underlier sponsor calculates the underlier</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 3pt; text-align: justify">Notes purchased on original issue date at the principal
    amount and held to the stated maturity date</P></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The actual performance of the underlier over the
life of your notes, as well as the cash settlement amount payable at maturity, if any, may bear little relation to the hypothetical examples
shown below or to the historical underlier levels shown elsewhere in this Pricing Supplement. For information about the historical levels
of the underlier during recent periods, see &ldquo;The Underlier &mdash; Historical Closing Levels of the Underlier&rdquo; below. Before
investing in the offered notes, you should consult publicly available information to determine the levels of the underlier between the
date of this Pricing Supplement and the date of your purchase of the offered notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Also, the hypothetical examples shown below do
not take into account the effects of applicable taxes. Because of the U.S. tax treatment applicable to your notes, tax liabilities could
affect the after-tax rate of return on your notes to a comparatively greater extent than the after-tax return on the underlier stocks.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The levels in the left column of the table below
represent hypothetical final underlier levels and are expressed as percentages of the initial underlier level. The amounts in the right
column represent the hypothetical cash settlement amounts, based on the corresponding hypothetical final underlier level, and are expressed
as percentages of the principal amount of a note (rounded to the nearest one-thousandth of a percent). Thus, a hypothetical cash settlement
amount of 100.000% means that the value of the cash payment that we would deliver for each $1,000 of the outstanding principal amount
of the offered notes on the stated maturity date would equal 100.000% of the principal amount of a note, based on the corresponding hypothetical
final underlier level and the assumptions noted above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 8pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 3pt; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Hypothetical Final
    Underlier Level</B></P>
                                                                              <P STYLE="font: 5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>
    <P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>(as Percentage of
    Initial Underlier Level)</B></P></TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-bottom: 3pt; text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Hypothetical Cash
    Settlement Amount</B></P>
                                                                              <P STYLE="font: 5pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>&nbsp;</B></P>
    <P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>(as Percentage of
    Principal Amount)</B></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">200.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">326.100%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">175.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">269.575%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">150.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">213.050%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">120.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">145.220%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">110.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">122.610%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">105.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">111.305%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">102.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">104.522%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">101.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">102.261%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #BFBFBF">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>100.000%</B></FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>100.000%</B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center; vertical-align: top; width: 50%; background-color: white; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">90.000%</FONT></TD>
    <TD STYLE="text-align: center; vertical-align: top; width: 50%; background-color: white; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">90.000%</FONT></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">75.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">75.000%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">60.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">60.000%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">50.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">50.000%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">25.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">25.000%</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">10.000%</FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">10.000%</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #BFBFBF">
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>0.000%</B></FONT></TD>
    <TD STYLE="text-align: center; padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><B>0.000%</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: rgb(187,8,38)">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">If, for example, the final underlier level were
determined to be 25.000% of the initial underlier level, the cash settlement amount that we would deliver on your notes at maturity would
be 25.000% of the principal amount of your notes, as shown in the table above. As a result, if you purchased your notes on the original
issue date at the principal amount and held them to the stated maturity date, you would lose 75.000% of your investment (if you purchased
your notes at a premium to principal amount you would lose a correspondingly higher percentage of your investment). If the final underlier
level were determined to be 0.000% of the initial underlier level, you would lose your entire investment in the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The following chart shows a graphical illustration
of the hypothetical cash settlement amounts that we would pay on your notes on the stated maturity date, if the final underlier level
were any of the hypothetical levels shown on the horizontal axis. The hypothetical cash settlement amounts in the chart are expressed
as percentages of the principal amount of your notes and the hypothetical final underlier levels are expressed as percentages of the initial
underlier level. The chart shows that any hypothetical final underlier level of less than 100.000% (the section left of the 100.000% marker
on the horizontal axis) would result in a hypothetical cash settlement amount of less than 100.000% of the principal amount of your notes
(the section below the 100.000% marker on the vertical axis) and, accordingly, in a loss of principal to the holder of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="tm257948d7_424b2img004.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The cash settlement amounts at maturity shown above
are entirely hypothetical; they are based on market prices for the underlier stocks that may not be achieved on the determination date
and on assumptions that may prove to be erroneous. The actual market value of your notes on the stated maturity date or at any other time,
including any time you may wish to sell your notes, may bear little relation to the hypothetical cash settlement amounts at maturity shown
above, and these amounts should not be viewed as an indication of the financial return on an investment in the offered notes. The hypothetical
cash settlement amounts on notes held to the stated maturity date in the examples above assume you purchased your notes at their principal
amount and have not been adjusted to reflect the actual issue price you pay for your notes. The return on your investment (whether positive
or negative) in your notes will be affected by the amount you pay for your notes. If you purchase your notes for a price other than the
principal amount, the return on your investment will differ from, and may be significantly lower than, the hypothetical returns suggested
by the above examples. Please read &ldquo;Risk Factors&mdash;Market Valuation Risks&mdash;The market value of the notes will be affected
by various factors that interrelate in complex ways, and their market value may be less than the principal amount&rdquo; in the accompanying
Underlying Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Payments on the notes are economically equivalent
to the amounts that would be paid on a combination of other instruments. For example, payments on the notes are economically equivalent
to a combination of an interest-bearing bond bought by the holder and one or more options entered into between the holder and us (with
one or more implicit option premiums paid over time). The discussion in this paragraph does not modify or affect the terms of the notes
or the U.S. federal income tax treatment of the notes, as described elsewhere in this Pricing Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 4pt 5.4pt; border: Black 1pt solid; text-align: justify; width: 100%"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">We cannot predict the actual final underlier level or what the market value of your notes will be on any particular trading day, nor can we predict the relationship between the underlier level and the market value of your notes at any time prior to the stated maturity date. The actual amount that you will receive, if any, at maturity and the rate of return on the offered notes will depend on the actual final underlier level determined by the calculation agent as described above. Moreover, the assumptions on which the hypothetical returns are based may turn out to be inaccurate. Consequently, the amount of cash to be paid in respect of your notes, if any, on the stated maturity date may be very different from the information reflected in the table and chart above.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>ADDITIONAL RISK FACTORS SPECIFIC TO YOUR NOTES</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding: 4pt 5.4pt; text-align: justify; width: 100%; border: Black 1pt solid"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><I>An investment in your notes is subject to the risks described below, as well as the risks and considerations described under &ldquo;Risk Factors&rdquo; in the accompanying Prospectus, Prospectus Supplement and Underlying Supplement. You should carefully review these risks and considerations as well as the terms of the notes described herein and in the accompanying Prospectus, Prospectus Supplement and Underlying Supplement. Your notes are a riskier investment than ordinary debt securities. Also, your notes are not equivalent to investing directly in the underlier stocks, i.e., the stocks comprising the underlier to which your notes are linked. You should carefully consider whether the offered notes are suited to your particular circumstances.</I></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B><I>Structure Risks</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>You May&nbsp;Lose Your Entire Investment in the
Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">You may lose your entire investment in the notes.
The cash payment on your notes, if any, on the stated maturity date will be based on the performance of the underlier as measured from
the initial underlier level to the closing level on the determination date. If the final underlier level is less than the initial underlier
level, you will lose, for each $1,000 of the principal amount of your notes, an amount equal to the product of (i)&nbsp;the underlier
return times (ii)&nbsp;$1,000. Thus, you may lose your entire investment in the notes, which would include any premium to principal amount
you paid when you purchased the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Also, the market price of your notes prior to the
stated maturity date may be significantly lower than the purchase price you pay for your notes. Consequently, if you sell your notes before
the stated maturity date, you may receive significantly less than the amount of your investment in the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The Amount Payable on Your Notes Is Not Linked
to the Level of the Underlier at Any Time Other than the Determination Date</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The final underlier level will be the closing level
of the underlier on the determination date (subject to adjustment as described in the accompanying Underlying Supplement). Therefore,
if the closing level of the underlier dropped precipitously on the determination date, the cash settlement amount for your notes may be
significantly less than it would have been had the cash settlement amount been linked to the closing level of the underlier prior to such
drop in the level of the underlier. Although the actual level of the underlier on the stated maturity date or at other times during the
life of your notes may be higher than the final underlier level, you will not benefit from the closing level of the underlier at any time
other than on the determination date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Your Notes Do Not Bear Interest</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">You will not receive any interest payments on your
notes. As a result, even if the cash settlement amount payable for your notes on the stated maturity date exceeds the principal amount
of your notes, the overall return you earn on your notes may be less than you would have earned by investing in a non-index-linked debt
security of comparable maturity that bears interest at a prevailing market rate.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B><I>Underlier Risks</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>An Investment in the Notes Is Subject to Risks
Associated with Foreign Securities</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The value of your notes is linked to an underlier
that is comprised of stocks from one or more foreign securities markets. Investments linked to the value of foreign equity securities
involve particular risks. Any foreign securities market may be less liquid, more volatile and affected by global or domestic market developments
in a different way than are the U.S. securities market or other foreign securities markets. Both government intervention in a foreign
securities market, either directly or indirectly, and cross-shareholdings in foreign companies, may affect trading prices and volumes
in that market. Also, there is generally less publicly available information about foreign companies than about those U.S. companies that
are subject to the reporting requirements of the SEC. Further, foreign companies are subject to accounting, auditing and financial reporting
standards and requirements that differ from those applicable to U.S. reporting companies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The prices of securities in a foreign country are
subject to political, economic, financial and social factors that are unique to such foreign country's geographical region. These factors
include: recent changes, or the possibility of future changes, in the applicable foreign government's economic and fiscal policies; the
possible implementation of, or changes in, currency exchange laws or other laws or restrictions applicable to foreign companies or investments
in foreign equity securities; fluctuations, or the possibility of fluctuations, in currency exchange rates; and the possibility of outbreaks
of hostility, political instability, natural disaster or adverse public health developments. The United Kingdom ceased to be a</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">member of the European Union on January&nbsp;31,
2020 (an event commonly referred to as &ldquo;Brexit&rdquo;). The effects of Brexit are uncertain, and, among other things, Brexit has
contributed, and may continue to contribute, to volatility in the prices of securities of companies located in Europe (or elsewhere) and
currency exchange rates, including the valuation of the euro and British pound in particular. Any one of these factors, or the combination
of more than one of these factors, could negatively affect such foreign securities market and the price of securities therein. Further,
geographical regions may react to global factors in different ways, which may cause the prices of securities in a foreign securities market
to fluctuate in a way that differs from those of securities in the U.S. securities market or other foreign securities markets. Foreign
economies may also differ from the U.S. economy in important respects, including growth of gross national product, rate of inflation,
capital reinvestment, resources and self-sufficiency, which may have a positive or negative effect on foreign securities prices.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>You Have No Shareholder Rights or Rights to Receive
Any Underlier Stock</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Investing in the notes will not make you a holder
of any of the underlier stocks. Neither you nor any other holder or owner of the notes will have any rights with respect to the underlier
stocks, including any voting rights, any right to receive dividends or other distributions, any rights to make a claim against the underlier
stocks or any other rights of a holder of the underlier stocks. Your notes will be paid in cash and you will have no right to receive
delivery of any underlier stocks.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>We Cannot Control Actions By Any of the Unaffiliated
Companies Whose Securities Are Included in the Underlier</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Actions by any company whose securities are included
in the underlier may have an adverse effect on the price of its security, the final underlier level and the value of the notes. These
companies will not be involved in the offering of the notes and will have no obligations with respect to the notes, including any obligation
to take our or your interests into consideration for any reason. These companies will not receive any of the proceeds of the offering
of the notes and will not be responsible for, and will not have participated in, the determination of the timing of, prices for, or quantities
of, the notes to be issued. These companies will not be involved with the administration, marketing or trading of the notes and will have
no obligations with respect to the cash settlement amount to be paid to you at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>We and Our Respective Affiliates Have No Affiliation
with the Underlier Sponsor and Have Not Independently Verified Its Public Disclosure of Information</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We and our respective affiliates are not affiliated
in any way with the underlier sponsor and have no ability to control or predict its actions, including any errors in or discontinuation
of disclosure regarding the methods or policies relating to the calculation of the underlier. We have derived the information about the
underlier sponsor and the underlier contained herein from publicly available information, without independent verification. You, as an
investor in the notes, should make your own investigation into the underlier and the underlier sponsor. The underlier sponsor is not involved
in the offering of the notes made hereby in any way and has no obligation to consider your interest as an owner of notes in taking any
actions that might affect the value of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The Historical Performance of the Underlier Should
Not Be Taken as an Indication of Its Future Performance</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The final underlier level will determine the amount
to be paid on the notes at maturity. The historical performance of the underlier does not necessarily give an indication of its future
performance. As a result, it is impossible to predict whether the level of the underlier will rise or fall during the term of the notes.
The level of the underlier will be influenced by complex and interrelated political, economic, financial and other factors.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B><I>Conflicts of Interest</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>There Are Potential Conflicts of Interest Between
You and the Calculation Agent</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The calculation agent will, among other things,
determine the cash settlement amount payable at maturity of the notes. We will serve as the calculation agent. We may appoint a different
calculation agent without your consent and without notifying you. The calculation agent will exercise its judgment when performing its
functions. For example, the calculation agent may have to determine whether a market disruption event affecting the underlier has occurred.
This determination may, in turn, depend on the calculation agent&rsquo;s judgment as to whether the event has materially interfered with
our ability or the ability of one of our affiliates or a similarly situated party to unwind our hedge positions. Since this determination
by the calculation agent will affect the payment at maturity on the notes, the calculation agent may have a conflict of interest if it
needs to make a determination of this kind. See &ldquo;Certain Terms of the Notes &mdash; Role of the Calculation Agent&rdquo; in the
accompanying Underlying Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Options: NewSection; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><B>Our
Economic Interests and Those of GS&amp;Co. and any Dealer Participating in the Offering of the Notes Will Potentially Be Adverse to Your
Interests</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">You should be aware of the following ways in which
our economic interests and those of GS&amp;Co. and any dealer participating in the distribution of the notes, which we refer to as a &ldquo;participating
dealer,&rdquo; will potentially be adverse to your interests as an investor in the notes. In engaging in certain of the activities described
below, our affiliates, GS&amp;Co. or its affiliates or any participating dealer or its affiliates may take actions that may adversely
affect the value of and your return on the notes, and in so doing they will have no obligation to consider your interests as an investor
in the notes. Our affiliates, GS&amp;Co. or its affiliates or any participating dealer or its affiliates may realize a profit from these
activities even if investors do not receive a favorable investment return on the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Research reports by our affiliates, GS&amp;Co.
or its affiliates or any participating dealer or its affiliates may be inconsistent with an investment in the notes and may adversely
affect the level of the underlier. </B>Our affiliates, GS&amp;Co. or its affiliates or any dealer participating in the offering of the
notes or its affiliates may, at present or in the future, publish research reports on the underlier or any underlier stocks. This research
will be modified from time to time without notice and may, at present or in the future, express opinions or provide recommendations that
are inconsistent with purchasing or holding the notes. Any research reports on the underlier or any underlier stocks could adversely affect
the level of the underlier and, therefore, adversely affect the value of and your return on the notes. You are encouraged to derive information
concerning the underlier from multiple sources and should not rely on the views expressed by us or our affiliates, GS&amp;Co. or its affiliates
or any participating dealer or its affiliates. In addition, any research reports on the underlier or any underlier stocks published on
or prior to the trade date could result in an increase in the level of the underlier on the trade date, which would adversely affect investors
in the notes by increasing the closing level at which the underlier must close on the determination date in order for investors in the
notes to receive a favorable return.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Hedging activities by our affiliates, GS&amp;Co.
or its affiliates or any participating dealer or its affiliates may adversely affect the level of the underlier. </B>We expect to hedge
our obligations under the notes through one or more hedge counterparties, which may include our affiliates, GS&amp;Co. or its affiliates
or any participating dealer or its affiliates. Pursuant to such hedging activities, our hedge counterparty may acquire any underlier stocks
and/or other instruments linked to the underlier or any underlier stocks. Depending on, among other things, future market conditions,
the aggregate amount and the composition of such positions are likely to vary over time. To the extent that our hedge counterparty has
a long hedge position in the underlier or any underlier stocks, or derivative or synthetic instruments related to the underlier or any
underlier stocks, they may liquidate a portion of such holdings at or about the time of the determination date or at or about the time
of a change in the underlier or any underlier stocks. These hedging activities could potentially adversely affect the level of the underlier
and, therefore, adversely affect the value of and your return on the notes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>Trading activities by our affiliates, GS&amp;Co.
or its affiliates or any participating dealer or its affiliates may adversely affect the level of the underlier. </B>Our affiliates, GS&amp;Co.
or its affiliates or any participating dealer or its affiliates may engage in trading in any underlier stocks and other instruments relating
to the underlier or any underlier stocks on a regular basis as part of their general broker-dealer and other businesses. Any of these
trading activities could potentially adversely affect the level of the underlier and, therefore, adversely affect the value of and your
return on the notes.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><B>A participating dealer or its affiliates may
realize hedging profits projected by its proprietary pricing models in addition to any selling concession or any distribution expense
fee, creating a further incentive for the participating dealer to sell the notes to you. </B>If any participating dealer or any of its
affiliates conducts hedging activities for us in connection with the notes, that participating dealer or its affiliates will expect to
realize a projected profit from such hedging activities, and this projected profit will be in addition to any concession or distribution
expense fee that the participating dealer receives for the sale of the notes to you. This additional projected profit may create a further
incentive for the participating dealer to sell the notes to you.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B><I>Tax Risks</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The U.S. Federal Tax Consequences of An Investment
in the Notes Are Unclear</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">There is no direct legal authority regarding the
proper U.S. federal tax treatment of the notes, and we do not plan to request a ruling from the U.S. Internal Revenue Service (the &ldquo;IRS&rdquo;).
Consequently, significant aspects of the tax treatment of the notes are uncertain, and the IRS or a court might not agree with the treatment
of the notes as prepaid cash-settled derivative contracts. If the IRS were successful in asserting an alternative treatment of the notes,
the tax consequences of</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">the ownership and disposition of the notes might
be materially and adversely affected. The U.S. Treasury Department and the IRS released a notice requesting comments on various issues
regarding the U.S. federal income tax treatment of &ldquo;prepaid forward contracts&rdquo; and similar instruments. See &ldquo;Material
U.S. Federal Income Tax Consequences&rdquo; in the accompanying Underlying Supplement. Any Treasury regulations or other guidance promulgated
after consideration of these issues could materially and adversely affect the tax consequences of an investment in the notes, including
the character and timing of income or loss and the degree, if any, to which income realized by non-U.S. persons should be subject to withholding
tax, possibly with retroactive effect. Both U.S. and non-U.S. persons considering an investment in the notes should review carefully the
section of the accompanying Underlying Supplement entitled &ldquo;Material U.S. Federal Income Tax Consequences&rdquo; and consult their
tax advisers regarding the U.S. federal tax consequences of an investment in the notes (including possible alternative treatments and
the issues presented by the notice), as well as tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>There Can Be No Assurance that the Canadian Federal
Income Tax Consequences of an Investment in the Notes Will Not Change in the Future</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">There can be no assurance that Canadian federal
income tax laws, the judicial interpretation thereof, or the administrative policies and assessing practices of the Canada Revenue Agency
will not be changed in a manner that adversely affects investors. For a discussion of the Canadian federal income tax consequences of
investing in the notes, please read the section of this Pricing Supplement entitled &ldquo;Certain Canadian Federal Income Tax Considerations&rdquo;
as well as the section entitled &ldquo;Material Income Tax Consequences &mdash; Canadian Taxation&rdquo; in the accompanying Prospectus.
You should consult your tax advisor with respect to your own particular situation.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B><I>General Risks</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The Notes Are Subject to the Credit Risk of the
Bank</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Although the return on the notes will be based
on the performance of the underlier, the payment of any amount due on the notes is subject to the credit risk of the Bank, as issuer of
the notes. The notes are our unsecured obligations. As further described in the accompanying Prospectus and Prospectus Supplement, the
notes will rank on par with all of the other unsecured and unsubordinated debt obligations of the Bank, except such obligations as may
be preferred by operation of law. Investors are dependent on our ability to pay all amounts due on the notes, and therefore investors
are subject to our credit risk and to changes in the market&rsquo;s view of our creditworthiness. See &ldquo;Description of Senior Debt
Securities &mdash; Ranking&rdquo; in the accompanying Prospectus.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The Bank&rsquo;s Initial Estimated Value of the
Notes at the Time of Pricing (When the Terms of Your Notes Were Set on the Trade Date) Is Lower Than the Initial Issue Price of the Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Bank&rsquo;s initial estimated value of the
notes is only an estimate. The initial issue price of the notes exceeds the Bank&rsquo;s initial estimated value. The difference between
the initial issue price of the notes and the Bank&rsquo;s initial estimated value reflects costs associated with selling and structuring
the notes, as well as hedging its obligations under the notes with a third party.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Bank&rsquo;s nor GS&amp;Co.&rsquo;s
Estimated Value of the Notes at Any Time Is Determined by Reference to Credit Spreads or the Borrowing Rate the Bank Would Pay for Its
Conventional Fixed-Rate Debt Securities</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Bank&rsquo;s initial estimated value of the
notes was determined and GS&amp;Co.&rsquo;s estimated value of the notes at any time are determined by reference to the Bank&rsquo;s internal
funding rate. The internal funding rate used in the determination of the estimated value of the notes generally represents a discount
from the credit spreads for the Bank&rsquo;s conventional fixed-rate debt securities and the borrowing rate the Bank would pay for its
conventional fixed-rate debt securities. This discount is based on, among other things, the Bank&rsquo;s view of the funding value of
the notes as well as the higher issuance, operational and ongoing liability management costs of the notes in comparison to those costs
for the Bank&rsquo;s conventional fixed-rate debt securities. If the interest rate implied by the credit spreads for the Bank&rsquo;s
conventional fixed-rate debt securities or the borrowing rate the Bank would pay for its conventional fixed-rate debt securities were
to be used, the Bank would expect the economic terms of the notes to be more favorable to you. Consequently, the use of an internal funding
rate for the notes increases the estimated value of the notes at any time and has an adverse effect on the economic terms of the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The Bank&rsquo;s Initial Estimated Value of the
Notes Does Not Represent Future Values of the Notes and May&nbsp;Differ From Others&rsquo; (Including GS&amp;Co.&rsquo;s) Estimates</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The Bank&rsquo;s initial estimated value of the
notes was determined by reference to its internal pricing models when the terms of the notes were set. These pricing models consider certain
factors, such as the Bank&rsquo;s internal funding rate on the trade</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B>&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; margin: 0pt 0">date, the expected term of the notes, market conditions
and other relevant factors existing at that time, and the Bank&rsquo;s assumptions about market parameters, which can include volatility,
dividend rates, interest rates and other factors. Different pricing models and assumptions (including the pricing models and assumptions
used by GS&amp;Co.) could provide valuations for the notes that are different, and perhaps materially lower, from the Bank&rsquo;s initial
estimated value. Therefore, the price at which GS&amp;Co. or any other party would buy or sell your notes (if GS&amp;Co. makes a market,
which it is not obligated to do) may be materially lower than the Bank&rsquo;s initial estimated value. In addition, market conditions
and other relevant factors in the future may change, and any assumptions may prove to be incorrect.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The Price at Which GS&amp;Co. Would Buy Or Sell
Your Notes (If GS&amp;Co. Makes a Market, Which It Is Not Obligated To Do) Will Be Based on GS&amp;Co.&rsquo;s Estimated Value of Your
Notes</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">GS&amp;Co.&rsquo;s estimated value of the notes
is determined by reference to its pricing models and takes into account the Bank&rsquo;s internal funding rate. The price at which GS&amp;Co.
would initially buy or sell your notes in the secondary market (if GS&amp;Co. makes a market, which it is not obligated to do) exceeds
GS&amp;Co.&rsquo;s estimated value of your notes at the time of pricing. As agreed by GS&amp;Co. and the distribution participants, this
excess (i.e., the additional amount described under &ldquo;Additional Information Regarding Estimated Value of the Notes&rdquo; above)
will decline to zero on a straight line basis over the period from the trade date through the applicable date set forth above under &ldquo;Additional
Information Regarding Estimated Value of the Notes&rdquo; above. Thereafter, if GS&amp;Co. buys or sells your notes, it will do so at
prices that reflect the estimated value determined by reference to GS&amp;Co.&rsquo;s pricing models at that time. The price at which
GS&amp;Co. will buy or sell your notes at any time also will reflect its then current bid and ask spread for similar sized trades of structured
notes. If GS&amp;Co. calculated its estimated value of your notes by reference to the Bank&rsquo;s credit spreads or the borrowing rate
the Bank would pay for its conventional fixed-rate debt securities (as opposed to the Bank&rsquo;s internal funding rate), the price at
which GS&amp;Co. would buy or sell your notes (if GS&amp;Co. makes a market, which it is not obligated to do) could be significantly lower.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">GS&amp;Co.&rsquo;s pricing models consider certain
variables, including principally the Bank&rsquo;s internal funding rate, interest rates (forecasted, current and historical rates), volatility,
price-sensitivity analysis and the time to maturity of the notes. These pricing models are proprietary and rely in part on certain assumptions
about future events, which may prove to be incorrect. As a result, the actual value you would receive if you sold your notes in the secondary
market, if any, to others may differ, perhaps materially, from the estimated value of your notes determined by reference to GS&amp;Co.&rsquo;s
models, taking into account the Bank&rsquo;s internal funding rate, due to, among other things, any differences in pricing models or assumptions
used by others. See &ldquo;Risk Factors&mdash;Market Valuation Risks&mdash;The market value of the notes will be affected by various factors
that interrelate in complex ways, and their market value may be less than the principal amount&rdquo; in the accompanying Underlying Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">In addition to the factors discussed above, the
value and quoted price of your notes at any time will reflect many factors and cannot be predicted. If GS&amp;Co. makes a market in the
notes, the price quoted by GS&amp;Co. would reflect any changes in market conditions and other relevant factors, including any deterioration
in the Bank&rsquo;s creditworthiness or perceived creditworthiness. These changes may adversely affect the value of your notes, including
the price you may receive for your notes in any market making transaction. To the extent that GS&amp;Co. makes a market in the notes,
the quoted price will reflect the estimated value determined by reference to GS&amp;Co.&rsquo;s pricing models at that time, plus or minus
GS&amp;Co.&rsquo;s then current bid and ask spread for similar sized trades of structured notes (and subject to the declining excess amount
described above).</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Furthermore, if you sell your notes, you will likely
be charged a commission for secondary market transactions, or the price will likely reflect a dealer discount. This commission or discount
will further reduce the proceeds you would receive for your notes in a secondary market sale.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">There is no assurance that GS&amp;Co. or any other
party will be willing to purchase your notes at any price and, in this regard, GS&amp;Co. is not obligated to make a market in the notes.
See &ldquo;&mdash;The Notes Will Not Be Listed on Any Securities Exchange and Your Notes May&nbsp;Not Have an Active Trading Market&rdquo;
below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The Notes Will Not Be Listed on Any Securities
Exchange and We Do Not Expect A Trading Market For the Notes to Develop</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The notes will not be listed on any securities
exchange. Although GS&amp;Co. and/or its affiliates may purchase the notes from holders, they are not obligated to do so and are not required
to make a market for the notes. There can be no assurance that a secondary market will develop for the notes. Because we do not expect
that any market makers will participate in a secondary market for the notes, the price at which you may be able to sell your notes is
likely to depend on the price, if any, at which GS&amp;Co. and/or its affiliates are willing to buy your notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="text-align: justify; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: justify; margin: 0pt 0">If a secondary market does exist, it may be limited.
Accordingly, there may be a limited number of buyers if you decide to sell your notes prior to maturity. This may affect the price you
receive upon such sale. Consequently, you should be willing to hold the notes to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>We May&nbsp;Sell an Additional Aggregate Principal
Amount of the Notes at a Different Issue Price</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">At our sole option, we may decide to sell an additional
aggregate principal amount of the notes subsequent to the trade date. The issue price of the notes in the subsequent sale may differ substantially
(higher or lower) from the initial issue price you paid as provided on the cover of this Pricing Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>If You Purchase Your Notes at a Premium to the
Principal Amount, the Return on Your Investment Will Be Lower Than the Return on Notes Purchased at the Principal Amount and the Impact
of Certain Key Terms of the Notes Will Be Negatively Affected</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The cash settlement amount will not be adjusted
based on the issue price you pay for the notes. If you purchase notes at a price that differs from the principal amount of the notes,
then the return on your investment in such notes held to the stated maturity date will differ from, and may be substantially less than,
the return on notes purchased at the principal amount. If you purchase your notes at a premium to the principal amount and hold them to
the stated maturity date, the return on your investment in the notes will be lower than it would have been had you purchased the notes
at the principal amount or a discount to the principal amount.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>THE UNDERLIER</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The EURO STOXX 50<SUP>&reg;</SUP> Index</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The underlier represents the performance of the
50 largest companies among the 20 supersectors in terms of free-float market capitalization in the Eurozone. For additional information
about the underlier, see the information set forth under &ldquo;Index Descriptions&mdash;The EURO STOXX 50<SUP>&reg;</SUP> Index&rdquo;
beginning on page&nbsp;S-12 of the accompanying Underlying Supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">In addition, information about the underlier may
be obtained from other sources, including, but not limited to, the underlier sponsor&rsquo;s website (including information regarding
the underlier&rsquo;s sector weightings). We are not incorporating by reference into this pricing supplement the website or any material
it includes. None of us, GS&amp;Co. or any of our respective affiliates makes any representation that such publicly available information
regarding the underlier is accurate or complete.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Historical Closing Levels of the Underlier</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The closing level of the underlier has fluctuated
in the past and may, in the future, experience significant fluctuations. Any historical upward or downward trend in the closing level
of the underlier during the period shown below is not an indication that the underlier is more or less likely to increase or decrease
at any time during the life of your notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>You should not
take the historical levels of the underlier as an indication of the future performance of the underlier.</B></FONT> We cannot give you
any assurance that the future performance of the underlier or the underlier stocks will result in your receiving an amount greater than
the outstanding principal amount of your notes on the stated maturity date.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">None of us, GS&amp;Co. or any of our respective
affiliates makes any representation to you as to the performance of the underlier. Before investing in the offered notes, you should consult
publicly available information to determine the levels of the underlier between the date of this Pricing Supplement and the date of your
purchase of the offered notes. The actual performance of the underlier over the life of the offered notes, as well as the cash settlement
amount at maturity, may bear little relation to the historical closing levels shown below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The graph below shows the daily historical closing
levels of the underlier from February&nbsp;28, 2015 through February&nbsp;28, 2025. On February&nbsp;28, 2025, the closing level of the
underlier was 5,463.54. We obtained the closing levels in the graph below from Bloomberg Financial Services, without independent verification.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Historical Performance of the EURO STOXX 50<SUP>&reg;</SUP>
    Index</B></P>

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="tm257948d7_424b2img002.jpg" ALT="" STYLE="width: 606px; height: 387px">&nbsp;</P>

<P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Source:
Bloomberg</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 16; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>SUPPLEMENTAL PLAN OF DISTRIBUTION</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">GS&amp;Co. has agreed to purchase the notes at
a discount reflecting commissions of $37.50 per $1,000 principal amount of notes. A fee will also be paid to iCapital Markets LLC (&ldquo;iCapital&rdquo;),
a broker-dealer with no affiliation with us, for services it is providing in connection with this offering. An affiliate of GS&amp;Co.
holds an indirect minority equity interest in iCapital. At the time we issue the notes, we will enter into certain hedging arrangements
(which may include call options, put options or other derivatives) with GS&amp;Co. or one of its affiliates.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">We will deliver the notes against payment therefor
in New York, New York on March&nbsp;7, 2025, which is the fifth scheduled business day following the trade date. Under Rule&nbsp;15c6-1
of the Securities Exchange Act of 1934, trades in the secondary market generally are required to settle in one business day, unless the
parties to any such trade expressly agree otherwise. Accordingly, purchasers who wish to trade notes on any date prior to one business
day before delivery will be required, by virtue of the fact that the notes will settle in five business days (T + 5), to specify alternative
settlement arrangements to prevent a failed settlement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">While GS&amp;Co. may make markets in the notes,
it is under no obligation to do so and may discontinue any market-making activities at any time without notice. The price that GS&amp;Co.
makes available from time to time after the issue date at which it would be willing to repurchase the notes will generally reflect its
estimate of their value. That estimated value will be based upon a variety of factors, including then prevailing market conditions, our
creditworthiness and transaction costs.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The price at which you purchase the notes includes
costs that the Bank. GS&amp;Co. or our or its affiliates expect to incur and profits that the Bank, GS&amp;Co. or our or its affiliates
expect to realize in connection with hedging activities related to the notes, as set forth above. These costs and profits will likely
reduce the secondary market price, if any secondary market develops, for the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>UNITED STATES FEDERAL INCOME TAX CONSIDERATIONS</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The following discussion is a brief summary of
the material U.S. federal income tax considerations relating to an investment in the notes. The following summary is not complete and
is both qualified and supplemented by the discussion entitled &ldquo;Material U.S. Federal Income Tax Consequences&rdquo; in the accompanying
Underlying Supplement, which you should carefully review prior to investing in the notes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The U.S. federal income tax considerations of your
investment in the notes are uncertain. No statutory, judicial or administrative authority directly discusses how the notes should be treated
for U.S. federal income tax purposes. In the opinion of our tax counsel, Mayer Brown LLP, it would generally be reasonable to treat the
notes as prepaid cash-settled derivative contracts. Pursuant to the terms of the notes, you agree to treat the notes in this manner for
all U.S. federal income tax purposes. If this treatment is respected, you should generally recognize capital gain or loss upon the sale,
exchange or payment upon maturity in an amount equal to the difference between the amount you receive in such transaction and the amount
that you paid for your notes. Such gain or loss should generally be treated as long-term capital gain or loss if you have held your notes
for more than one year.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">The expected characterization of the notes is not
binding on the IRS or the courts. It is possible that the IRS would seek to characterize the notes in a manner that results in tax consequences
to you that are different from those described above or in the accompanying Underlying Supplement. Such alternate treatments could include
a requirement that a holder accrue ordinary income over the life of the notes or treat all gain or loss at maturity as ordinary gain or
loss. For a more detailed discussion of certain alternative characterizations with respect to the notes and certain other considerations
with respect to an investment in the notes, you should consider the discussion set forth in &ldquo;Material U.S. Federal Income Tax Consequences&rdquo;
of the accompanying Underlying Supplement. We are not responsible for any adverse consequences that you may experience as a result of
any alternative characterization of the notes for U.S. federal income tax or other tax purposes.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">With respect to the discussion in the Underlying
Supplement regarding &ldquo;dividend equivalent&rdquo; payments, the IRS has issued a notice that provides that withholding on dividend
equivalent payments will not apply to specified ELIs that are not delta-one instruments and that are issued before January&nbsp;1, 2027.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>CERTAIN CANADIAN FEDERAL INCOME TAX CONSIDERATIONS</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">In the opinion of
Blake, Cassels&nbsp;&amp; Graydon LLP, our Canadian tax counsel, the following summary describes the principal Canadian federal income
tax considerations under the <I>Income Tax Act</I> (Canada) and the regulations thereto (the &ldquo;Canadian Tax Act&rdquo;) generally
applicable at the date hereof to a purchaser who acquires beneficial ownership of a note pursuant to this Pricing Supplement and who for
the purposes of the Canadian Tax Act and at all relevant times: (a)&nbsp;is neither resident nor deemed to be resident in Canada; (b)&nbsp;deals
at arm&rsquo;s length with CIBC and any transferee resident (or deemed to be resident) in Canada to whom the purchaser disposes of the
note; (c)&nbsp;does not use or hold and is not deemed to use or hold the note in, or in the course of, carrying on a business in Canada;
(d)&nbsp;is entitled to receive all payments (including any interest and principal) made on the note; (e)&nbsp;is not a, and deals at
arm&rsquo;s length with any, &ldquo;specified shareholder&rdquo; of CIBC for purposes of the thin capitalization rules&nbsp;in the Canadian
Tax Act; and (f)&nbsp;is not an entity in respect of which CIBC or any transferee resident (or deemed to be resident) in Canada to whom
the purchaser disposes of, loans or otherwise transfers the note is a &ldquo;specified entity&rdquo;, and is not a &ldquo;specified entity&rdquo;
in respect of such a transferee, in each case, for purposes of the Hybrid</FONT> Mismatch Rules, as defined below (a &ldquo;Non-Resident
Holder&rdquo;). Special rules&nbsp;which apply to non-resident insurers carrying on business in Canada and elsewhere are not discussed
in this summary.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-size: 10pt">This </FONT>summary
assumes that no amount paid or payable to a holder described herein will be the deduction component of a &ldquo;hybrid mismatch arrangement&rdquo;
under which the payment arises within the meaning of the rules&nbsp;in the Canadian Tax Act with respect to &ldquo;hybrid mismatch arrangements&rdquo;
(the &ldquo;Hybrid Mismatch Rules&rdquo;). Investors should note that the Hybrid Mismatch Rules&nbsp;are highly complex and there remains
significant uncertainty as to their interpretation and application.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">This summary is supplemental to and should be read
together with the description of material Canadian federal income tax considerations relevant to a Non-Resident Holder owning notes under
 &ldquo;Material Income Tax Consequences &mdash; Canadian Taxation&rdquo; in the accompanying Prospectus and a Non-Resident Holder should
carefully read that description as well.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"><B>This summary is of a general nature only and
is not intended to be, nor should it be construed to be, legal or tax advice to any particular Non-Resident Holder. Non-Resident Holders
are advised to consult with their own tax advisors with respect to their particular circumstances.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Based on Canadian tax counsel&rsquo;s understanding
of the Canada Revenue Agency&rsquo;s administrative policies and having regard to the terms of the notes, interest payable on the notes
should not be considered to be &ldquo;participating debt interest&rdquo; as defined in the Canadian Tax Act and accordingly, a Non-Resident
Holder should not be subject to Canadian non-resident withholding tax in respect of amounts paid or credited or deemed to have been paid
or credited by CIBC on a note as, on account of or in lieu of payment of, or in satisfaction of, interest.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">Non-Resident Holders should consult their own advisors
regarding the consequences to them of a disposition of the notes to a person with whom they are not dealing at arm&rsquo;s length for
purposes of the Canadian Tax Act.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><B>VALIDITY OF THE NOTES</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">In the opinion of Blake, Cassels&nbsp;&amp; Graydon
LLP, as Canadian counsel to the Bank, the issue and sale of the notes has been duly authorized by all necessary corporate action of the
Bank in conformity with the indenture, and when the notes have been duly executed, authenticated and issued in accordance with the indenture,
the notes will be validly issued and, to the extent validity of the notes is a matter governed by the laws of the Province of Ontario
or the federal laws of Canada applicable therein, will be valid obligations of the Bank, subject to applicable bankruptcy, insolvency
and other laws of general application affecting creditors&rsquo; rights, equitable principles, and subject to limitations as to the currency
in which judgments in Canada may be rendered, as prescribed by the <I>Currency Act</I> (Canada). This opinion is given as of the date
hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable therein. In addition, this opinion
is subject to customary assumptions about the Trustee&rsquo;s authorization, execution and delivery of the indenture and the genuineness
of signature, and to such counsel&rsquo;s reliance on the Bank and other sources as to certain factual matters, all as stated in the opinion
letter of such counsel dated June&nbsp;6, 2023, which has been filed as Exhibit&nbsp;5.2 to the Bank&rsquo;s Registration Statement on
Form&nbsp;F-3 filed with the SEC on June&nbsp;6, 2023.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">In the opinion of Mayer Brown LLP, when the notes
have been duly completed in accordance with the indenture and issued and sold as contemplated by this Pricing Supplement and the accompanying
Underlying Supplement, Prospectus Supplement and Prospectus, the notes will constitute valid and binding obligations of the Bank, entitled
to the benefits of the indenture, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws
of general applicability relating to or affecting creditors&rsquo; rights and to general equity principles. This opinion is given as of
the date hereof and is limited to the laws of the State of New York. This opinion is subject to customary assumptions about the Trustee&rsquo;s
authorization, execution and delivery of the indenture and such counsel&rsquo;s reliance on the Bank and other sources as to certain factual
matters, all as stated in the legal opinion dated June&nbsp;6, 2023, which has been filed as Exhibit&nbsp;5.1 to the Bank&rsquo;s Registration
Statement on Form&nbsp;F-3 filed with the SEC on June&nbsp;6, 2023.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 13.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0826"><B>Leveraged EURO STOXX 50<SUP>&reg;
</SUP>Index-Linked Notes due March&nbsp;4, 2030</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We have not authorized anyone to provide any information
or to make any representations other than those contained or incorporated by reference in this Pricing Supplement or the accompanying
Underlying Supplement, Prospectus Supplement or Prospectus. We take no responsibility for, and can provide no assurance as to the reliability
of, any other information that others may give you. Neither this Pricing Supplement nor the accompanying Underlying Supplement, Prospectus
Supplement or Prospectus is an offer to sell only the notes offered hereby, but only under circumstances and in jurisdictions where it
is lawful to do so. The information contained in this Pricing Supplement and the accompanying Underlying Supplement, Prospectus Supplement
and Prospectus is current only as of the respective dates of such documents.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font-size: 6.5pt">
    <TD STYLE="font-size: 6.5pt; text-align: left; vertical-align: bottom; width: 89%"><P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">TABLE
    OF CONTENTS</FONT></P>
    <P STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">&nbsp;</FONT></P></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; width: 11%; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; vertical-align: bottom; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Pricing
    Supplement</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; vertical-align: top; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Page</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Additional
    Information Regarding Estimated Value of the Notes</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-1</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">About this
    Pricing Supplement</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-2</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Summary
    Information</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-3</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Supplemental
    Terms of the Notes</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-5</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Hypothetical
    Examples</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-6</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Additional
    Risk Factors Specific to Your Notes</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-9</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The Underlier</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-15</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Supplemental
    Plan of Distribution</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-16</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">United States
    Federal Income Tax Considerations</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-17</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Certain
    Canadian Federal Income Tax Considerations</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-18</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Validity
    of the Notes</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">PRS-19</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Equity Index
    Underlying Supplement dated September&nbsp;5, 2023</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Risk Factors</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-1</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Use of Proceeds
    and Hedging</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-9</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Index Descriptions</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-10</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    Dow Jones Industrial Average<SUP>&reg;</SUP></FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-10</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    EURO STOXX 50<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-12</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    EURO STOXX<SUP>&reg;</SUP> Banks Index</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-14</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    FTSE<SUP>&reg;</SUP> 100 Index</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-15</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    Hang Seng Index</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-17</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    JPX-Nikkei Index 400</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-19</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    MSCI Indices</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-21</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    Nasdaq-100 Index<SUP>&reg;</SUP></FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-26</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    Nikkei Stock Average Index</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-29</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    Russell Indices</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-31</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    S&amp;P<SUP>&reg;</SUP>/ASX 200 Index</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-34</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    S&amp;P Select Industry Indices</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-37</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    S&amp;P Select Sector Indices</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-40</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    S&amp;P U.S. Indices</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-43</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    Swiss Market Index<SUP>&reg;</SUP></FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-48</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; padding-left: 0.375in; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The
    TOPIX<SUP>&reg;</SUP> Index</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-50</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Certain
    Terms of the Notes</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-52</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">The Bank&rsquo;s
    Estimated Value of the Notes</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-58</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Material
    Canadian Federal Income Tax Consequences</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-59</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Material
    U.S. Federal Income Tax Consequences</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-59</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Prospectus
    Supplement dated September&nbsp;5, 2023</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">About this
    Prospectus Supplement</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-1</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Risk Factors</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-1</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Use of Proceeds</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-14</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Description
    of the Notes We May&nbsp;Offer</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-15</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Supplemental
    Plan of Distribution (Conflicts of Interest)</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">S-45</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left">&nbsp;</TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Prospectus
    dated September&nbsp;5, 2023</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">About this
    Prospectus</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">i</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Forward-Looking
    Statements</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">i</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Available
    Information</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">iii</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Documents
    Incorporated by Reference</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">iii</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Presentation
    of Financial Information</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">iv</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Canadian
    Imperial Bank of Commerce</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">iv</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Risk Factors</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">1</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Use of Proceeds</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">1</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Description
    of Senior Debt Securities</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">1</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Material
    Income Tax Consequences</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">23</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Plan of
    Distribution (Conflicts of Interest)</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">34</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Certain
    Considerations for U.S. Plan Investors</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">38</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Limitations
    on Enforcement of U.S. Laws Against CIBC,&nbsp;Its Management and Others</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">39</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Validity
    of Securities</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">40</FONT></TD></TR>
  <TR STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif">
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">Experts</FONT></TD>
    <TD STYLE="font: 6.5pt Arial, Helvetica, Sans-Serif; text-align: center"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 6.5pt">40</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 21; Options: NewSection; Value: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="font: 8pt Arial, Helvetica, Sans-Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">PRS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 17pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center; color: #bb0025"><B>$4,725,000</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Arial, Helvetica, Sans-Serif; border-collapse: collapse">
  <TR STYLE="background-color: rgb(238,236,225); vertical-align: top">
    <TD STYLE="padding: 5.4pt; text-align: center; width: 100%"><P STYLE="text-align: center; font: 17pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; color: #bb0026"><B>Canadian
    Imperial Bank of Commerce</B></P>
    <P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #bb0826"><B>Senior
    Global Medium-Term Notes</B></P>
    <P STYLE="font: 17pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #bb0826"><B>Leveraged
    EURO STOXX 50<SUP>&reg;</SUP> Index-Linked Notes</B></P>
    <P STYLE="font: 17pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center; color: #bb0826"><B>due
    March 4, 2030</B></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="tm257948d7_424b2img003.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT><B>Goldman Sachs&nbsp;&amp;
Co. LLC</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>tm257948d7_ex-filingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2">
  <head>
    <title>EX-FILING FEES</title>
  </head>
  <body>
    <div style="display: none">
      <ix:header>
        <ix:hidden>
          <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-36">F-3</ix:nonNumeric>
          <ix:nonNumeric name="ffd:SubmissnTp" contextRef="rc" id="ixv-37">424B2</ix:nonNumeric>
          <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="rc" id="ixv-38">EX-FILING FEES</ix:nonNumeric>
          <ix:nonNumeric name="ffd:RegnFileNb" contextRef="rc" id="ixv-39">333-272447</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="rc" id="ixv-40">0001045520</ix:nonNumeric>
          <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-41">CANADIAN IMPERIAL BANK OF COMMERCE /CAN/</ix:nonNumeric>
        </ix:hidden>
        <ix:references>
          <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd" xlink:type="simple"/>
        </ix:references>
        <ix:resources>
          <xbrli:context id="rc">
            <xbrli:entity>
              <xbrli:identifier scheme="http://www.sec.gov/CIK">0001045520</xbrli:identifier>
            </xbrli:entity>
            <xbrli:period>
              <xbrli:startDate>2025-02-28</xbrli:startDate>
              <xbrli:endDate>2025-02-28</xbrli:endDate>
            </xbrli:period>
          </xbrli:context>
          <xbrli:unit id="USD">
            <xbrli:measure>iso4217:USD</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="pure">
            <xbrli:measure>xbrli:pure</xbrli:measure>
          </xbrli:unit>
          <xbrli:unit id="Shares">
            <xbrli:measure>xbrli:shares</xbrli:measure>
          </xbrli:unit>
        </ix:resources>
      </ix:header>
    </div>
    <div>
      <table style="width: 99%; font-family: Arial, Helvetica, sans-serif; font-size: 20pt; text-align: center;">
        <tr>
          <td colspan="4" style="padding-bottom: .5em">
            <p>
              <b>Calculation of Filing Fee Tables</b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="ffd:FormTp" contextRef="rc" id="ixv-57">F-3</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
        <tr>
          <td style="padding-bottom: .25em">
            <p>
              <b>
                <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="rc" id="ixv-58">CANADIAN IMPERIAL BANK OF COMMERCE /CAN/</ix:nonNumeric>
              </b>
            </p>
          </td>
        </tr>
      </table>
    </div>
    <div style="padding-bottom: 20px;">
      <table style="float: center; width: 100%; text-align: left;">
        <tbody>
          <tr style="font-family: Arial, Helvetica, sans-serif; font-size: 16px">
            <th style="vertical-align: bottom; text-align: center; width: 90%;">
              <b>Narrative Disclosure</b>
            </th>
          </tr>
        </tbody>
      </table>
      <table style="font-family: Arial, Helvetica, sans-serif; font-size: 16px; float: center; width: 100%; text-align: center; margin-left:auto; margin-right:auto;">
        <tbody>
          <tr>
            <td>
					 The maximum aggregate offering price of the securities to which the prospectus relates is <span>$</span><ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="rc" id="ixv-59">4,725,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="rc" format="ixt:booleantrue" id="ixv-60">The prospectus is a final prospectus for the related offering.</ix:nonNumeric>
				</td>
          </tr>
          <tr>
            <td>
              <div style="padding-top: 20px;">
                <ix:nonNumeric name="ffd:NrrtvDsclsr" contextRef="rc" escape="1" id="ixv-61"> </ix:nonNumeric>
              </div>
            </td>
          </tr>
        </tbody>
      </table>
    </div>
  </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm257948d7_424b2img001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm257948d7_424b2img001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Z +,# 2(  A$! Q$!_\0
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MSL-*MR57:V!.W=SZCT_/O3##8>5>?*MNI[8/%'A\C(UW3#_V]Q_XTH\3Z 2
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>[I96&#(WJ?3T K8HHJTK'ESG*I)SD[MA11100?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm257948d7_424b2img002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm257948d7_424b2img002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &# EX# 2(  A$! Q$!_\0
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M =117+_V_P")_P#H2Y__  8P?XT?V_XG_P"A+G_\&,'^- '445R_]O\ B?\
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MP?XT =117+_V_P")_P#H2Y__  8P?XT?V_XG_P"A+G_\&,'^- '445R_]O\
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MJ\N;ZS\R\L6L;A6*O TBR%>X^9>#D$&KU !1110 5');Q2RQ2O&&>$EHV/\
M"2""1^!(_&I** "BBB@"GJW_ "!K[_KWD_\ 035RJ>K?\@:^_P"O>3_T$U<H
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0\7?^"IO\:/^%BK_ -"AXN_\%3?XUVE% '%_\+%7_H4/%W_@J;_&C_A8J_\
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M '\H_P"%C>#O^ABL?^_E '445R__  L;P=_T,5C_ -_*/^%C>#O^ABL?^_E
M'445R_\ PL;P=_T,5C_W\H_X6-X._P"ABL?^_E '445R_P#PL;P=_P!#%8_]
M_*/^%C>#O^ABL?\ OY0!U%%<O_PL;P=_T,5C_P!_*/\ A8W@[_H8K'_OY0!U
M%%<O_P +&\'?]#%8_P#?RC_A8W@[_H8K'_OY0!U%%<O_ ,+&\'?]#%8_]_*/
M^%C>#O\ H8K'_OY0!U%%<O\ \+&\'?\ 0Q6/_?RC_A8W@[_H8K'_ +^4 =11
M7+_\+&\'?]#%8_\ ?RC_ (6-X._Z&*Q_[^4 =117+_\ "QO!W_0Q6/\ W\H_
MX6-X._Z&*Q_[^4 =117+_P#"QO!W_0Q6/_?RC_A8W@[_ *&*Q_[^4 =117+_
M /"QO!W_ $,5C_W\H_X6-X._Z&*Q_P"_E '445R__"QO!W_0Q6/_ '\H_P"%
MC>#O^ABL?^_E '445R__  L;P=_T,5C_ -_*/^%C>#O^ABL?^_E '445R_\
MPL;P=_T,5C_W\H_X6-X._P"ABL?^_E '445R_P#PL;P=_P!#%8_]_*/^%C>#
MO^ABL?\ OY0!U%%<O_PL;P=_T,5C_P!_*/\ A8W@[_H8K'_OY0!U%%<O_P +
M&\'?]#%8_P#?RC_A8W@[_H8K'_OY0!U%%<O_ ,+&\'?]#%8_]_*/^%C>#O\
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M72%X)1AU#%21]001^%9=GX;33=2%U97=X$EG\ZX2>ZDEWCRO+"C<3W"MDY/
M&<   &3IGCV.\>Z:ZM[>UBMXYI&0SR&8K'G)53$JMP,\.< U>7Q/<) 6N=-2
M.:2.&2VC2XWB3S7$:ACM&T[F7. 1SP35N3PY#=7 >_OKR]A7?LMYRFQ=ZLC?
M=4$_*S#DGK4<?A:V6WDBEO+R<E(XXI)&3= L;;DVX4#A@#E@2<#.: "74VN=
M!UD7D4=K/:+)#,JR[T!,8<$,0N00Z]0.:7_A-/"O_0S:-_X'Q?\ Q5/FTU-/
MT'5%\Z6XDGCDEFFFV[I&V;<G: /NJHX Z4O_  B?AO\ Z%_2O_ */_"@"/\
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M?^AFT;_P/B_^*J3_ (1/PW_T+^E?^ 4?^%'_  B?AO\ Z%_2O_ */_"@"/\
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M?^AFT;_P/B_^*J3_ (1/PW_T+^E?^ 4?^%'_  B?AO\ Z%_2O_ */_"@"/\
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M)%1[.(D ^N!4J2>QK4H5*=^=6L[/U+?_  FGA7_H9M&_\#XO_BJ/^$T\*_\
M0S:-_P"!\7_Q52?\(GX;_P"A?TK_ , H_P#"C_A$_#?_ $+^E?\ @%'_ (51
MB1_\)IX5_P"AFT;_ ,#XO_BJ/^$T\*_]#-HW_@?%_P#%5)_PB?AO_H7]*_\
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M??\ 7O)_Z":N5C2:BFI:#J;"":WEACEBEAF"[T8)G!VD@\$'@G@ULT %%%%
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MP-_T 8_^_P#+_P#%4?\ "IO W_0!C_[_ ,O_ ,57:44 <7_PJ;P-_P! &/\
M[_R__%4?\*F\#?\ 0!C_ ._\O_Q5=I10!Q?_  J;P-_T 8_^_P#+_P#%4?\
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M_"IO W_0!C_[_P O_P 51_PJ;P-_T 8_^_\ +_\ %5VE%:'(<7_PJ;P-_P!
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MY_=<_P#!K-_\51_PJK0?^?W7/_!K-_\ %4S,[BBN'_X55H/_ #^ZY_X-9O\
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M;JYNI9<;2P/!8J%;: "1G)_/'MY=&E\ 75P;_4K?789X[>&)-0F",IP=VT$
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MD.FVH(5?G?+%LN?O8/IFM>BBA))60ISE.3G)W;"BBBF0%%%% !1110 4444
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MH4G_ ()[>@#M**XO_A&?&O\ T4*3_P $]O1_PC/C7_HH4G_@GMZ .THKB_\
MA&?&O_10I/\ P3V]'_",^-?^BA2?^">WH [2BN+_ .$9\:_]%"D_\$]O1_PC
M/C7_ **%)_X)[>@#M**XO_A&?&O_ $4*3_P3V]'_  C/C7_HH4G_ ()[>@";
MXG.(O -_,?\ EE) _P"4R4OPTTK^R? FG)YOF&Y071^7&W> V/?'K7->-?#?
MBF/P=J<FH>,WOK6.(.]L=,AC\S# @;EY'(!X]*U['P?XPL;"VM(/'K1101+$
MD:Z3"P15   )Y.,=3S67+^]OY'H.K; JFNLG^2_4[NBN+_X1GQK_ -%"D_\
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M&'I4]%% [NU@HHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'_ONY_PHS\3?[GA'_ONY_P *[2B@#B\_$W^YX1_[[N?\*,_$W^YX1_[[N?\
M"NTHH XO/Q-_N>$?^^[G_"C/Q-_N>$?^^[G_  KM** .+S\3?[GA'_ONY_PH
MS\3?[GA'_ONY_P *[2B@#B\_$W^YX1_[[N?\*,_$W^YX1_[[N?\ "NTHH XO
M/Q-_N>$?^^[G_"C/Q-_N>$?^^[G_  KM** .+S\3?[GA'_ONY_PHS\3?[GA'
M_ONY_P *[2B@#B\_$W^YX1_[[N?\*,_$W^YX1_[[N?\ "NTHH XO/Q-_N>$?
M^^[G_"C/Q-_N>$?^^[G_  KM** .+S\3?[GA'_ONY_PHS\3?[GA'_ONY_P *
M[2B@#B\_$W^YX1_[[N?\*,_$W^YX1_[[N?\ "NTHH XO/Q-_N>$?^^[G_"C/
MQ-_N>$?^^[G_  KM** .+S\3?[GA'_ONY_PHS\3?[GA'_ONY_P *[2B@#B\_
M$W^YX1_[[N?\*,_$W^YX1_[[N?\ "NTHH XO/Q-_N>$?^^[G_"C/Q-_N>$?^
M^[G_  KM** .+S\3?[GA'_ONY_PHS\3?[GA'_ONY_P *[2B@#B\_$W^YX1_[
M[N?\*,_$W^YX1_[[N?\ "NTHH XO/Q-_N>$?^^[G_"C/Q-_N>$?^^[G_  KM
M** .+S\3?[GA'_ONY_PHS\3?[GA'_ONY_P *[2B@#B\_$W^YX1_[[N?\*,_$
MW^YX1_[[N?\ "NTHH XO/Q-_N>$?^^[G_"C/Q-_N>$?^^[G_  KM** .+S\3
M?[GA'_ONY_PHS\3?[GA'_ONY_P *[2B@#B\_$W^YX1_[[N?\*,_$W^YX1_[[
MN?\ "NTHH XO/Q-_N>$?^^[G_"C/Q-_N>$?^^[G_  KM** .+S\3?[GA'_ON
MY_PHS\3?[GA'_ONY_P *[2B@#B\_$W^YX1_[[N?\*,_$W^YX1_[[N?\ "NTH
MH XO/Q-_N>$?^^[G_"C/Q-_N>$?^^[G_  KM** .+S\3?[GA'_ONY_PHS\3?
M[GA'_ONY_P *[2B@#B\_$W^YX1_[[N?\*,_$W^YX1_[[N?\ "NTHH RM _M/
M['+_ &R+,:AYI\T698Q?=7&W=STQG/?-:M5[?_7W?_74?^@+5B@ HHHH **@
MOA"=/N1<S>3 8F\R7S/+V+@Y;=_#@<Y[5SGA#5M*&E1V-OJ,4[?;KF")5F\Y
ML>;,Z9.2<&-"03U ZT =517ENG(^F:DXTR^M=4U2:.[P(Y)C) X5V3>I<IC(
M5.54\C&>35BTEMDTJZ&G7US+:O;6C:C(;AW:-FE E.2<HWE[RP&,8' H [[5
MO^0-??\ 7O)_Z":N5R%@P3PKKR:6XNK*-Y5LFDN&96C\I2V)#N) <R8Z],56
M_M3XD_\ 0M:'_P"#)_\ XB@#N**X?^U/B3_T+6A_^#)__B*/[4^)/_0M:'_X
M,G_^(H [BBN'_M3XD_\ 0M:'_P"#)_\ XBC^U/B3_P!"UH?_ (,G_P#B* .X
MHKA_[4^)/_0M:'_X,G_^(H_M3XD_]"UH?_@R?_XB@#N**X?^U/B3_P!"UH?_
M (,G_P#B*/[4^)/_ $+6A_\ @R?_ .(H [BBN'_M3XD_]"UH?_@R?_XBC^U/
MB3_T+6A_^#)__B* .XHKA_[4^)/_ $+6A_\ @R?_ .(H_M3XD_\ 0M:'_P"#
M)_\ XB@#N**X?^U/B3_T+6A_^#)__B*/[4^)/_0M:'_X,G_^(H [BBN'_M3X
MD_\ 0M:'_P"#)_\ XBC^U/B3_P!"UH?_ (,G_P#B* .XHKA_[4^)/_0M:'_X
M,G_^(H_M3XD_]"UH?_@R?_XB@#N**X?^U/B3_P!"UH?_ (,G_P#B*/[4^)/_
M $+6A_\ @R?_ .(H [BBN'_M3XD_]"UH?_@R?_XBC^U/B3_T+6A_^#)__B*
M.XHKA_[4^)/_ $+6A_\ @R?_ .(H_M3XD_\ 0M:'_P"#)_\ XB@#N**X?^U/
MB3_T+6A_^#)__B*/[4^)/_0M:'_X,G_^(H [BBN'_M3XD_\ 0M:'_P"#)_\
MXBC^U/B3_P!"UH?_ (,G_P#B* .XHKA_[4^)/_0M:'_X,G_^(H_M3XD_]"UH
M?_@R?_XB@#N**X?^U/B3_P!"UH?_ (,G_P#B*/[4^)/_ $+6A_\ @R?_ .(H
M [BBN'_M3XD_]"UH?_@R?_XBC^U/B3_T+6A_^#)__B* .XHKA_[4^)/_ $+6
MA_\ @R?_ .(H_M3XD_\ 0M:'_P"#)_\ XB@#N**X?^U/B3_T+6A_^#)__B*/
M[4^)/_0M:'_X,G_^(H [BBN'_M3XD_\ 0M:'_P"#)_\ XBC^U/B3_P!"UH?_
M (,G_P#B* .XHKA_[4^)/_0M:'_X,G_^(H_M3XD_]"UH?_@R?_XB@#N**X?^
MU/B3_P!"UH?_ (,G_P#B*/[4^)/_ $+6A_\ @R?_ .(H [BBN'_M3XD_]"UH
M?_@R?_XBC^U/B3_T+6A_^#)__B* .XHKA_[4^)/_ $+6A_\ @R?_ .(H_M3X
MD_\ 0M:'_P"#)_\ XB@#N**X?^U/B3_T+6A_^#)__B*/[4^)/_0M:'_X,G_^
M(H [BBN'_M3XD_\ 0M:'_P"#)_\ XBC^U/B3_P!"UH?_ (,G_P#B* .XHKA_
M[4^)/_0M:'_X,G_^(H_M3XD_]"UH?_@R?_XB@#N**X?^U/B3_P!"UH?_ (,G
M_P#B*/[4^)/_ $+6A_\ @R?_ .(H [BBN'_M3XD_]"UH?_@R?_XBC^U/B3_T
M+6A_^#)__B* .XHKA_[4^)/_ $+6A_\ @R?_ .(H_M3XD_\ 0M:'_P"#)_\
MXB@#N**X?^U/B3_T+6A_^#)__B*/[4^)/_0M:'_X,G_^(H [BBN'_M3XD_\
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M_A,+K_H3_$G_ 'Y@_P#CM=110!R__"877_0G^)/^_,'_ ,=H_P"$PNO^A/\
M$G_?F#_X[7444 <O_P )A=?]"?XD_P"_,'_QVC_A,+K_ *$_Q)_WY@_^.UU%
M% '+_P#"877_ $)_B3_OS!_\=H_X3"Z_Z$_Q)_WY@_\ CM=110!R_P#PF%U_
MT)_B3_OS!_\ ':/^$PNO^A/\2?\ ?F#_ ..UU%% '+_\)A=?]"?XD_[\P?\
MQVC_ (3"Z_Z$_P 2?]^8/_CM=110!R__  F%U_T)_B3_ +\P?_':/^$PNO\
MH3_$G_?F#_X[7444 <O_ ,)A=?\ 0G^)/^_,'_QVC_A,+K_H3_$G_?F#_P".
MUU%% '+_ /"877_0G^)/^_,'_P =H_X3"Z_Z$_Q)_P!^8/\ X[7444 <O_PF
M%U_T)_B3_OS!_P#':/\ A,+K_H3_ !)_WY@_^.UU%% '+_\ "877_0G^)/\
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MC0!VE%<7_P +%7_H4/%W_@J;_&C_ (6*O_0H>+O_  5-_C0!VE%<7_PL5?\
MH4/%W_@J;_&C_A8J_P#0H>+O_!4W^- ':45Q?_"Q5_Z%#Q=_X*F_QH_X6*O_
M $*'B[_P5-_C0!VE%<7_ ,+%7_H4/%W_ (*F_P :/^%BK_T*'B[_ ,%3?XT
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MO_!4W^- ':45Q?\ PL5?^A0\7?\ @J;_ !H_X6*O_0H>+O\ P5-_C0!UEO\
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M 9O_ (FC_A/]"_O7W_@#-_\ $UT]%%I=_P  M+O^!S'_  G^A?WK[_P!F_\
MB:/^$_T+^]??^ ,W_P 373U#=S/;V<\T<1E>.-G6->KD#( ^M%I=_P  M+O^
M!SO_  L#0<XWWN?3[#+_ /$TO_"?Z%_>OO\ P!F_^)KA]&\3:P;[2;]OB#H^
MKRWT\$4VAV]G$LB+(P#896,G[L,S'<.BG->OT6EW_ +2[_@<Q_PG^A?WK[_P
M!F_^)H_X3_0O[U]_X S?_$UT]%%I=_P"TN_X',?\)_H7]Z^_\ 9O_B:/^$_T
M+^]??^ ,W_Q-=/11:7?\ M+O^!S'_"?Z%_>OO_ &;_XFD'Q T$@$/>D'H18R
M_P#Q-2^-]5N](\.-/9WD-C))/%"U].F^.U5F ,C#H0.G) R1FL#P3J^H-XA?
M2I?&.G^*;4V;3^?9V\47V1E=%5&\HE?F#,1GGY#1:7?\ M+O^!M_\)_H7]Z^
M_P# &;_XFC_A/]"_O7W_ ( S?_$UT]%%I=_P"TN_X',?\)_H7]Z^_P# &;_X
MFC_A/]"_O7W_ ( S?_$UT]%%I=_P"TN_X',?\)_H7]Z^_P# &;_XFD/Q T$=
M7O1_VXR__$UU%>>>-]:U!/$L.D1>+M.\+6HM$N1=7EO'(;AR[ HOF$*-NU2>
M<_.*+2[_ (!:7?\  W/^$_T+^]??^ ,W_P 31_PG^A?WK[_P!F_^)I/ 6LWV
MM:#.]_/%>/;7<EM'J$*;([Y%QB9 . #DKP2,J<&NHHM+O^ 6EW_ YC_A/]"_
MO7W_ ( S?_$T?\)_H7]Z^_\  &;_ .)KIZ*+2[_@%I=_P.8_X3_0O[U]_P"
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MX:US4HO%FGV)\>:5XJAOS)YT5I:Q1O;!8RPD)B)^7*JGS8^\,5Z?5EH****
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M%&]"&"YWX+*_.1ZUH^&K]M1T6.5[.VLV1WB,-K<)/$I5B"%9<#J",$ @@C%
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M%=/&$@ 38#B-%W$+QELF@!(?'MC+K@T9M/OH[Z5)GM8F: FY,8RRKB0[6(Y
MDV>^.:Y_PU\56NO!.EZSKVE3QW5_.T$ M!&([E@\@^0-+E0H3YC(5&3QD5HZ
M)\*- T'7=.U>SEN_M&GM,8MRPC>)%*D2,L89\ G!9B1GJ:0?"?0O[#M]&>ZO
MI;&SG,]E%,()!:DEBP4-&=X)<Y$F_H,8H Z+PSXFL/%>FR7NGB55BG>WECE
M#1R+C*G!([CD$CFMFL?PYX;LO#&G265CS')*9F/DQ198@#[L2(O11VK8H **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm257948d7_424b2img003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm257948d7_424b2img003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !- .,# 2(  A$! Q$!_\0
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MZBK?A;Q5>^%=0:XM@)89!ME@=B%<>OL1V/N?6O;?%OA.T\5:=Y4F(KN/)@N
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L>EVUM!96T=M;1+%#$H5$48"BI:*:BEL88C%UL1;VLKV"BBBF<H4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm257948d7_424b2img004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm257948d7_424b2img004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &\ JP# 2(  A$! Q$!_\0
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MXW\UH K?V:O_ #]7?_?\T?V:O_/U=_\ ?\U=HH I?V:O_/U=_P#?\T?V:O\
MS]7?_?\ -7:* ,^?3PL$C"[O 0I(_?GTI_\ 9J_\_5W_ -_S5FX_X]I?]P_R
MJ2@"E_9J_P#/U=_]_P T?V:O_/U=_P#?\U=HH I?V:O_ #]7?_?\T?V:O_/U
M=_\ ?\U=HH SX]/!>4&[O.&P/WY]!3_[-7_GZN_^_P":LQ?ZR;_?_P#914E
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M5EO^/E/]QOYK4E %+^S5_P"?J[_[_FC^S5_Y^KO_ +_FKM% %+^S5_Y^KO\
M[_FH+VP\NPN'6[O RQ,01.>#@UJ55U-E32KQW8*JP.22< #:: ..^(NM)X6\
M-.T-Y>_;[O,-L!,>#CEOP!_,BM#P?X?U&P\.6ZZQJNH7%_+^]E,ET[;,]$R2
M>@_7-<?X?1_B)\1+C7[E'.C:4VRR4_<=P>#SW_B/_ 17K=8P;G)SZ=#T\5&.
M'I1P]O>WEZ]%\EOYE+^S5_Y^KO\ [_FC^S5_Y^KO_O\ FKM%;'F%+^S5_P"?
MJ[_[_FH(+#=-= W=X0LH _?G@;%/]36I5:V_X^+S_KL/_1:4 1_V:O\ S]7?
M_?\ -']FK_S]7?\ W_-7:* *7]FK_P _5W_W_-']FK_S]7?_ '_-7:* ,N>P
MVS6H%W> -*0?WYY&QC_05/\ V:O_ #]7?_?\U)<_\?%G_P!=C_Z+>K- %+^S
M5_Y^KO\ [_FC^S5_Y^KO_O\ FKM% %+^S5_Y^KO_ +_FJ=_878")9S7+;CAG
M:X/RU-=0:A<WRH)?)M5PVY#R?\_E6G7$W+$J=.TH):7V;[VW=O/[C:RIM2T?
MD4=%D>70=.DD=G=K:-F9CDL2HR2>YJ]6?H/_ "+VF?\ 7I%_Z *T*[3$****
M "BBB@ HHHH **** .?\9?\ (#MO^PKIO_I;#705S_C+_D!VW_85TW_TMAKH
M* .?O/\ DH>C?]@J_P#_ $;:5T%<_>?\E#T;_L%7_P#Z-M*Z"@ HHHH ****
M "BBB@ HHHH **** "O.5L=3C\<"?SY(YS?EFGDU)#"UN2<1"#[P;:0HXZC.
M:]&KR>U5!XWEW?V9&W]KL0DFCR22G][U$^S )Z@YPN>. * /6**** "BBB@
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M4E1M_P ?*?[C?S6I* "BBB@ KR_XM:]<2I;>$=,0R7E_AYMI^[&#D _7!)]
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M_P"^?_KTZB@#/T'_ )%[3/\ KTB_] %:%9^@_P#(O:9_UZ1?^@"M"@ HHHH
M**** "BBB@ HHHH Y_QE_P @.V_["NF_^EL-=!7/^,O^0';?]A73?_2V&N@H
M Y^\_P"2AZ-_V"K_ /\ 1MI705S]Y_R4/1O^P5?_ /HVTKH* "BBB@ HHHH
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M25'%_K)O]_\ ]E%24 %%%% !4<_^K'^^O_H0J2HY_P#5C_?7_P!"% $E%%%
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M+/\ Z['_ -%O5FMB HHHH **** ,_0?^1>TS_KTB_P#0!6A6?H/_ "+VF?\
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MJ,R?W5_[Z_\ K4ZB@!N9/[J_]]?_ %J,R?W5_P"^O_K4ZB@""(R>9-\J_?\
M[W^R/:I<R?W5_P"^O_K4V+_63?[_ /[**DH ;F3^ZO\ WU_]:C,G]U?^^O\
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M_P"^O_K49D_NK_WU_P#6IU% #<R?W5_[Z_\ K49D_NK_ -]?_6IU% &?H/\
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M*#K\6DWNJ^%7F%P?.A1Y?.V;B2JX^7(7H#S@#=SF@#T&BBB@ HHHH *KWO\
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M_P!]?_6IU% #<R?W5_[Z_P#K5% 9/+/RK]]OXO\ :/M4]1P?ZL_[[?\ H1H
M=F3^ZO\ WU_]:C,G]U?^^O\ ZU.HH ;F3^ZO_?7_ -:N*^)GBF7P[X<-O; _
M;]0S!!Y;?,O'S,/<9P/<BNSN)X;6WDN+B18H8E+N[G 51R237E7A*"7QYX^N
M_%MY$W]F6+>5IZMT+#H<>P)8^[#TK&K)_#'=GH8&E&[KU?AAKZOHOF_P1U?@
M3PN?"FA6UHP1KJ56FN'SCYSMXZ= ,#\SWKK,R?W5_P"^O_K4UO\ CY3_ '&_
MFM25K&*BK(XZM656;J3W8W,G]U?^^O\ ZU&9/[J_]]?_ %J=13,QN9/[J_\
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M_=7_ +Z_^M3J* &YD_NK_P!]?_6HS)_=7_OK_P"M3J* ,_0?^1>TS_KTB_\
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M%9/_ $BNJ -[<?\ GFWZ?XT;C_SS;]/\:=10!!$Q\R;]VWW_ &_NCWJ7<?\
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M;?I_C3J* &[C_P \V_3_ !HW'_GFWZ?XTZB@!NX_\\V_3_&JULQ^T7G[MO\
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MJTNK^&9=-LHKF*VU%I;EGEV>4A@ECW=#D?O"?J .^0 =)1110!'%_K)O]_\
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MRG^XW\UJ2HV_X^4_W&_FM25T$!1110 56U#_ )!MU_UQ?^1JS5;4/^0;=?\
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M3J* &^8/1O\ ODU6U"0?V;=<-_J7_A/H:MU6U#_D&W7_ %Q?^1H G\P>C?\
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MBBB@ HHHH CN/^/:7_</\JDJ.X_X]I?]P_RJ2@ HHHH **** (XO]9-_O_\
MLHJ2HXO]9-_O_P#LHJ2@ HHHH *CG_U8_P!]?_0A4E1S_P"K'^^O_H0H DHJ
M"\O;;3[22[O)XX+>(9>21L "O+[[Q%X@^(FHOI?A;S;+0U;9<:DRE6<=\?\
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M?\@.V_["NF_^EL-=!0!S]Y_R4/1O^P5?_P#HVTKH*Y^\_P"2AZ-_V"K_ /\
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MMJ]3_P!.\-:GF1_WU_.LW2O^0EKG_7\O_I/#6I0 WS(_[Z_G1YD?]]?SIU%
M#?,C_OK^=1-)']I3YU^XW?W6IZC;_CY3_<;^:T .\R/^^OYT>9'_ 'U_.G44
M -\R/^^OYT>9'_?7\Z=10!!<21_9I?G7[A[^U2^9'_?7\Z;<?\>TO^X?Y5)0
M WS(_P"^OYT>9'_?7\Z=10 WS(_[Z_G1YD?]]?SIU% $$4D?F3?.OW_7_9%2
M^9'_ 'U_.FQ?ZR;_ '__ &45)0 WS(_[Z_G1YD?]]?SIU% #?,C_ +Z_G6#X
ML\6:7X7TL75[+N=G B@C.7D(.>/;W/'Z5A>*OB&MK<G1/#41U+79#L41+O2$
M]RQ[D>G0=_2JGAWX>3"Z_MWQ?.-2U9G39&[;XXAD?@3[=!V]:PE4;?+3U?X(
M]*EA(4XJKB79=%]J7^2\W\C+MM$UGXGW$.J^(IO[.T1#NMK&,X=Q_>.?7^\?
MP !S7J5C:V6FV45G9I%#;Q*%1$P !5K&!@45<*:CKU[F&(Q4ZUH[16R6R_S?
MFQOF1_WU_.CS(_[Z_G3J*T.0;YD?]]?SJM9+#! R(XP9I7Y8=6=F/ZFK=4],
MB>&T=9/O&XG8<YX,KD?H10!:\R/^^OYT>9'_ 'U_.G44 -\R/^^OYUG7>DZ?
M=3BY4FVNE;<+BVD\MR?]K'#CV8$>U:=% &.QU*VN$\NYM;U=C8$W[I^HY+*"
M#]-HI1XBLXIQ!?B2PD(RIN<"-OI("4S[9S[5IM_Q\I_N-_-:DZT ,6:)E#+(
MA!Y!##FE\R/^^OYU1;1;)6+VRO9R$YW6K&,$^I4?*Q_W@:+2+5;>Y:.XN(+N
MU)^61E\N5!CH0 5?GN-F!V- %[S(_P"^OYU6U"1/[-NOG7_4OW]C60=:OU^(
MB:"Z6WV"32Y+Q&"MYN]9(TY.<8^<\8[#GM7.+XZOI[/S;FQ1[>_TV^O(+>&-
MA/;B# *298AF;=C@+A@1@]: /0_,C_OK^='F1_WU_.N%M_%NNSK=6L=O97-Y
M]AM-0BF@B<QQ1S2%65UWY<HJL_#+O X"U!H?Q,&J:_I=C=0+:0WMLFS,;L9;
MA@2=C=/+!CD4-SN(R,#!8 ]!\R/^^OYT>9'_ 'U_.G44 -\R/^^OYU6MI$^T
M7GSK_KAW_P!A*MU6MO\ CXO/^NP_]%I0!/YD?]]?SH\R/^^OYTZB@!OF1_WU
M_.CS(_[Z_G3J* *ES(GVBS^=?]<>_P#L/5GS(_[Z_G4%S_Q\6?\ UV/_ *+>
MK- #?,C_ +Z_G1YD?]]?SIU% #?,C_OK^='F1_WU_.G44 9^@_\ (O:9_P!>
MD7_H K0K/T'_ )%[3/\ KTB_] %:% !1110 4444 %%%% !1110!S_C+_D!V
MW_85TW_TMAKH*Y_QE_R [;_L*Z;_ .EL-=!0!S]Y_P E#T;_ +!5_P#^C;2N
M@KG[S_DH>C?]@J__ /1MI704 %%%% !1110 4444 %%%% !1110!2UCS!I%R
M\5[)9,B;S<1Q"5D"\G"D'/ (Q@]>.:\WTO59+G6K.]MM4N[W4);X6TJ_V0B,
MT E*EFE\D$#:NXKD$9QD$5Z?=QS36<\5M/\ 9YWC98YM@?RV(X;:>#@\X[UY
MKI\=Y_:R6E_XRN+B"TU-#)$NG"-9)7ED*CS,YVET92!D _+T% 'J%%%% !11
M10 57O?]0O\ UUC_ /0UJQ5>]_U"_P#76/\ ]#6@"GI7_(2US_K^7_TGAK4K
M+TK_ )"6N?\ 7\O_ *3PUJ4 %%%% !4;?\?*?[C?S6I*C;_CY3_<;^:T 244
M44 %%%% $=Q_Q[2_[A_E4E1W'_'M+_N'^524 %%%% !1110!'%_K)O\ ?_\
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M.#5JZGB>TAD#KMDEBVG<.?G'3UJ&30K":R%I+$7AV2J59NIDSO;_ 'CEN?\
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M^NQ_]%O5F@ HHHH **** ,_0?^1>TS_KTB_] %:%9^@_\B]IG_7I%_Z *T*
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M!7/^,O\ D!VW_85TW_TMAKH* .?O/^2AZ-_V"K__ -&VE=!7/WG_ "4/1O\
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MS_KL/_1:4 6:*** "BBB@"M<_P#'Q9_]=C_Z+>K-5KG_ (^+/_KL?_1;U9H
M**** "BBB@#/T'_D7M,_Z](O_0!6A6?H/_(O:9_UZ1?^@"M"@ HHHH ****
M"BBB@ HHHH Y_P 9?\@.V_["NF_^EL-=!7/^,O\ D!VW_85TW_TMAKH* .?O
M/^2AZ-_V"K__ -&VE=!7/WG_ "4/1O\ L%7_ /Z-M*Z"@ HHHH **** "BBB
M@ HHHH **** "O+$ALXO'D\!UW2E$^I13.J.YN&E221EC(QM!_>",\]%'&<U
MZ'KL,L^B7:075S;2!-XEM4WRC:=Q"KW) QCWKS70'U3[=:&TN_$TJOJ1$T4U
MKY<.T3$.S.5P"0"67@Y)&<\T >M5#)=VT4Z0R7$22OC:C. S?0=ZFJA=V$]U
M?P2FYC^RQ88VSP[@SALAL[AR,#'& >>3C !9AN[:XDDCAN(I7C.'5'#%3TY
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M!W)X%>B^'O#>F>%].%EID'EH>9'8Y>1O5CW_ )#M6C#:PV\*0P1B.) %1$)
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M\UJ2HV_X^4_W&_FM:PA&"LCAKUZE>7/4=_T\EV)****LP"BBB@".X_X]I?\
M</\ *I*CN/\ CVE_W#_*I* "BBB@ HHHH CB_P!9-_O_ /LHJ2HXO]9-_O\
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M "BBB@".XDDBMI9(83/*B%DB#!2Y X7)X&>F37F]O9GQ!XBN8]7\.ZE>RP7
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ME-R_.VX+@]4'RC'<*!QDUL6UK<&QBBO;CS)E?>SHH&0&RH/'88&0!G&>,XH
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M\U?G).T_-YJX'3C_ %?^<4_RM1_Y[?\ D5?_ (U0!H45G^5J/_/;_P BK_\
M&J/*U'_GM_Y%7_XU0!H56U#_ )!MU_UQ?^1J#RM1_P">W_D5?_C5174-_P#9
M)MQ>5=C9C25=SC'0?NQR: -6BL_RM1_Y[?\ D5?_ (U1Y6H_\]O_ "*O_P :
MH T**S_*U'_GM_Y%7_XU1Y6H_P#/;_R*O_QJ@#0JM;?\?%Y_UV'_ *+2H/*U
M'_GM_P"15_\ C5110W_FSX+H=XRS2KASM7D?N^G0?4&@#5HK/\K4?^>W_D5?
M_C5'E:C_ ,]O_(J__&J -"BL_P K4?\ GM_Y%7_XU1Y6H_\ /;_R*O\ \:H
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M_P!+8:Z"N?\ &7_(#MO^PKIO_I;#704 <_>?\E#T;_L%7_\ Z-M*Z"N?O/\
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MM7G%LYDA*3R1%&(QD%&!Z50/P[\+-IZ63Z<[Q)*9D=[N9I48@ [92^]00HR
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M-,2-=-G:XM=KN-LI&"Y.?G)_VLUOT4 <P/AYX573I+ :2OV=[PWQ'G2;A.0
M7#;MRY  P"![4X_#_P +'3KC3QI$2VT]VU\R*[@K.P +H0<IP ,*0!Z5TM%
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M/^>$GYBM@@'J :38O]T?E7F5Z&-E4;I5E&/;EO\ C<WA.DE:4;OU$BD$L22
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M=<_\$5[_ /&:Z"B@#G_^$RTO_GUUS_P17O\ \9H_X3+2_P#GUUS_ ,$5[_\
M&:Z"B@#G_P#A,M+_ .?77/\ P17O_P 9H_X3+2_^?77/_!%>_P#QFN@HH Y_
M_A,M+_Y]=<_\$5[_ /&:/^$RTO\ Y]=<_P#!%>__ !FN@HH Y_\ X3+2_P#G
MUUS_ ,$5[_\ &:/^$RTO_GUUS_P17O\ \9KH** .?_X3+2_^?77/_!%>_P#Q
MFC_A,M+_ .?77/\ P17O_P 9KH** .?_ .$RTO\ Y]=<_P#!%>__ !FC_A,M
M+_Y]=<_\$5[_ /&:Z"B@#G_^$RTO_GUUS_P17O\ \9H_X3+2_P#GUUS_ ,$5
M[_\ &:Z"B@#G_P#A,M+_ .?77/\ P17O_P 9H_X3+2_^?77/_!%>_P#QFN@H
MH Y__A,M+_Y]=<_\$5[_ /&:/^$RTO\ Y]=<_P#!%>__ !FN@HH Y_\ X3+2
M_P#GUUS_ ,$5[_\ &:/^$RTO_GUUS_P17O\ \9KH** .?_X3+2_^?77/_!%>
M_P#QFC_A,M+_ .?77/\ P17O_P 9KH** .?_ .$RTO\ Y]=<_P#!%>__ !FC
M_A,M+_Y]=<_\$5[_ /&:Z"B@#G_^$RTO_GUUS_P17O\ \9H_X3+2_P#GUUS_
M ,$5[_\ &:Z"B@#G_P#A,M+_ .?77/\ P17O_P 9H_X3+2_^?77/_!%>_P#Q
MFN@HH Y__A,M+_Y]=<_\$5[_ /&:/^$RTO\ Y]=<_P#!%>__ !FN@HH Y_\
MX3+2_P#GUUS_ ,$5[_\ &:/^$RTO_GUUS_P17O\ \9KH** .?_X3+2_^?77/
M_!%>_P#QFC_A,M+_ .?77/\ P17O_P 9KH** .?_ .$RTO\ Y]=<_P#!%>__
M !FC_A,M+_Y]=<_\$5[_ /&:Z"B@#G_^$RTO_GUUS_P17O\ \9H_X3+2_P#G
MUUS_ ,$5[_\ &:Z"B@#G_P#A,M+_ .?77/\ P17O_P 9H_X3+2_^?77/_!%>
M_P#QFN@HH Y__A,M+_Y]=<_\$5[_ /&:/^$RTO\ Y]=<_P#!%>__ !FN@HH
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: 'FCW<2A4NHG8EGC"@!5)R2.E=I110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46190635616416">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Feb. 28, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0001045520<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">CANADIAN IMPERIAL BANK OF COMMERCE /CAN/<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-272447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46190631087936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Feb. 28, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 4,725,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M"VW:S T+<Z^!M!O,>B:$/@>VUX:;,OD'4$L#!!0    ( .Z#9%IZ 5O)Z (
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M4,*_A2)/*#I0B'C22)O-FKWZ\X'U/+_%K7V)Z]#?R>7C -[/2]]02P,$%
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MJO>K=-KX,U\-[\GF$U!+ 0(4 Q0    ( .Z#9%H'04UB@0   +$    0
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M96QS+RYR96QS4$L! A0#%     @ [H-D6B-A4GE- 0  N0(   \
M     ( !%A$  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( .Z#9%J-]RQ:
MM    (D"   :              "  9 2  !X;"]?<F5L<R]W;W)K8F]O:RYX
M;6PN<F5L<U!+ 0(4 Q0    ( .Z#9%INIR2\'@$  %<$   3
M  "  7P3  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     *  H A (  ,L4
$      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>9</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm257948d7_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="tm257948d7_ex-filingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="tm257948d7_ex-filingfees.htm">tm257948d7_ex-filingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="8">http://xbrl.sec.gov/ffd/2024q2</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tm257948d7_ex-filingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "tm257948d7_ex-filingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
     ]
    }
   },
   "keyStandard": 9,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 6,
    "http://xbrl.sec.gov/ffd/2024q2": 4,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024q2": 8,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": null,
     "uniqueAnchor": null
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "rc",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm257948d7_ex-filingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "rc",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tm257948d7_ex-filingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024q2",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001104659-25-020352-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-25-020352-xbrl.zip
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M1*2']:N\5R$%/C;0BSVU\@8I+WGBTJ=JN%0&?2'%P%>Y"IG['U!+ 0(4 Q0
M   ( .Z#9%J'UGEW,04  !,2   <              "  0    !T;3(U-SDT
K.&0W7V5X+69I;&EN9V9E97,N:'1M4$L%!@     !  $ 2@   &L%      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>tm257948d7_ex-filingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024q2"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024q2/ffd-2024q2.xsd"
      xlink:type="simple"/>
    <context id="rc">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001045520</identifier>
        </entity>
        <period>
            <startDate>2025-02-28</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <ffd:FormTp contextRef="rc" id="ixv-36">F-3</ffd:FormTp>
    <ffd:SubmissnTp contextRef="rc" id="ixv-37">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="rc" id="ixv-38">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:RegnFileNb contextRef="rc" id="ixv-39">333-272447</ffd:RegnFileNb>
    <dei:EntityCentralIndexKey contextRef="rc" id="ixv-40">0001045520</dei:EntityCentralIndexKey>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-41">CANADIAN IMPERIAL BANK OF COMMERCE /CAN/</dei:EntityRegistrantName>
    <ffd:FormTp contextRef="rc" id="ixv-57">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="rc" id="ixv-58">CANADIAN IMPERIAL BANK OF COMMERCE /CAN/</dei:EntityRegistrantName>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="rc" decimals="INF" id="ixv-59" unitRef="USD">4725000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="rc" id="ixv-60">true</ffd:FnlPrspctsFlg>
    <ffd:NrrtvDsclsr contextRef="rc" id="ixv-61"> </ffd:NrrtvDsclsr>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
